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Abstract 
 
  This study was carried out at Alshaab Teaching Hospital, Khartoum, to evaluate 
the prevalence of Mycobacterium infection in patients visiting the out patient 
clinic during the period from February 2007 to February 2008. A total of 279 
patients were included in this study and interviewed according to a prestructure 
questionnaire. Patients were divided into groups according to age, sex and 
occupation.  
All patients were examined for reactivity to tuberculin skin test (TST) and 
the presence of acid fast bacilli (AFB) in their sputum. All AFB positive sputum 
samples were cultured on Löwenstein-Jensen (LJ) medium for the isolation of 
Mycobacterium tuberculosis.  In this study, the prevalence of Mycobacterium 
infection as measured by TST was 62% among 279 patients studied. Patient’s 
positive for TST gave skin induration as delayed type hypersensitivity (DTH) 
tissue reaction, manifested as an area of induration measuring 10mm to 25mm in 
diameter. All BCG vaccinated patients were TST positive. The prevalence of 
Mycobacterium infection in males was 37.6% and in females was 24.4%, whereas 
AFB were demonstrated in 11.9% of males and 6.3% of females.   
Age group of the patients found mostly affected was from 15 to 45 years 
old, which represented 74% of TST-positive cases and 92.6% AFB-positive cases. 
No AFB was demonstrated in age group less than 15 years old. However, the 
prevalence of Mycobacterium infection as measured by TST was high among 
student due to BCG vaccination. The demonstration of AFB in sputum samples 
was found highest in employees (3.2 %.) 
In this study AFB was demonstrated in 27 (9.7%) of the sputum samples 
and no AFB was demonstrated in BCG vaccinated individuals. All isolates were 
                                        XIV
identified as M. tuberculosis by their growth characteristics in additions to specific 
biochemical tests.  
The prevalence of the disease (9.7%) among the study population is 
considered high and it is attributed to the fact that samples were collected from 
referred patients highly suspected of tuberculosis.  
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 اﻟﻤﺴﺘﺨﻠﺺ
 اﻹﺻﺎﺑﺔ ﺑﺎﻟﻤﺘﻔﻄﺮة اﻟﺴﻠﻴﺔ ﻓﻲ اﻟﻌﻴﺎدة  أﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻓﻲ  ﻣﺴﺘﺸﻔﻰ اﻟﺸﻌﺐ اﻟﺘﻌﻠﻴﻤﻲ ، اﻟﺨﺮﻃﻮم ﻟﺘﻘﻴﻴﻢ
 ﺷﺨﺼﺎ وﻓﻘﺎ ﻟﻠﻤﻘﺎﺑﻼت 972اﺳﺔ  وﺷﻤﻠﺖ  اﻟﺪر.8002 اﻟﻰ ﻓﺒﺮاﻳﺮ 7002اﻟﺨﺎرﺟﻴﺔ ﻓﻲ اﻟﻔﺘﺮة ﻣﻦ ﻓﺒﺮاﻳﺮ 
ﺟﻤﻴﻊ اﻻﺷﺨﺎص أﺧﻀﻌﻮا . وﺗﻢ ﺗﻘﺴﻴﻢ اﻻﺷﺨﺎص إﻟﻰ ﻣﺠﻤﻮﻋﺎت ﺣﺴﺐ اﻟﻌﻤﺮ، اﻟﺠﻨﺲ، واﻟﻤﻬﻨﺔ. واﻻﺳﺘﺒﻴﺎن
وﻓﺤﺺ اﻟﺒﻠﻐﻢ  وﺟﻤﻴﻊ  اﻟﻌﻴﻨﺎت اﻟﻤﻮﺟﺒﺔ ﻟﻔﺤﺺ اﻟﺒﻠﻐﻢ زرﻋﺖ  ( اﻟﺴﻠﻴﻦ)ﻹﺧﺘﺒﺎر اﻟﺴﻞ ﺑﻔﺤﺺ اﻟﺠﻠﺪ اﻟﺘﻘﻠﻴﺪي 
 .ﺴﺒﺒﺔ ﻟﻠﻤﺮضﻓﻲ وﺳﻂ  اﻟﻤﺘﻔﻄﺮة اﻟﺴﻠﻴﺔ ﻟﻌﺰل اﻟﺒﻜﺘﻴﺮﻳﺎ اﻟﻤ
  إﺧﺘﺒﺎر اﻟﺴﻠﻴﻦﻣﻮﺟﺒﻮااﻻﺷﺨﺎص . %26ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ آﺎن اﻧﺘﺸﺎر اﻟﻌﺪوى ﺑﺎﻟﻤﺘﻔﻄﺮة اﻟﺴﻠﻴﺔ 
  وﺟﻤﻴﻊ اﻻﺷﺨﺎص اﻟﻤﺤﺼﻨﻴﻦ  . ﻣﻠﻢ52 إﻟﻲﻣﻠﻢ 01أﻋﻄﻮا رد ﻓﻌﻞ ﻣﻨﻄﻘﺔ إرﺗﺸﺎح ﺑﻘﻴﺎس ﻗﻄﺮ ﻳﺘﺮاوح ﻣﻦ 
  ﺑﻴﻨﻤﺎ اﻹﻧﺎث %6.73ر ﻟﻠﺰآﻮﻦ  إﻳﺠﺎﺑﻴﺔ اﻟﺴﻠﻴآﺎﻧﺖ ﻧﺴﺒﺔ.أﻋﻄﻮا إﻳﺠﺎﺑﻴﺔ ﻟﺘﻔﺎﻋﻞ اﻟﺴﻠﻴﻦ ( اﻟﺒﻲ ﺳﻲ ﺟﻲ)ﺑﻠﻘﺎح 
  . ﻟﻺﻧﺎث%3.6ر و  ﻟﻠﺬآﻮ% 9.11  ﻓﻲ ﺣﻴﻦ إﻳﺠﺎﺑﻴﺔ ﻓﺤﺺ اﻟﺒﻠﻐﻢ آﺎﻧﺖ . %4.42آﺎﻧﺖ 
 ﻋﺎﻣﺎ ، واﻟﺘﻲ ﺗﻤﺜﻞ 54 إﻟﻲ 51 اﻟﻔﺌﺎت اﻟﻌﻤﺮﻳﺔ اﻷآﺜﺮ ﺗﺄﺛﺮا ﺑﺎﻟﻌﺪوى  آﺎن ﻣﻌﻈﻤﻬﻢ ﻓﻲ اﻟﻤﺪى ﻣﻦ 
 ﻋﺎﻣﺎ 51 اﻟﻔﺌﺎت اﻟﻌﻤﺮﻳﺔ أﻗﻞ ﻣﻦ وﻟﻢ ﺗﻈﻬﺮ. إﻳﺠﺎﺑﻴﺔ ﻓﺤﺺ اﻟﺒﻠﻐﻢ% 6.29   إﻳﺠﺎﺑﻴﺔ ﻟﺘﻔﺎﻋﻞ اﻟﺴﻠﻴﻦ  و%47
  .اﻳﺠﺎﺑﻴﺔ ﻟﻬﺬا اﻟﻔﺤﺺ
 ﻧﺴﺒﺔ اﻧﺘﺸﺎر  ﺑﻴﻨﻤﺎ آﺎﻧﺖ ﻧﺴﺒﺔ اﻧﺘﺸﺎر إﻳﺠﺎﺑﻴﺔ ﺗﻔﺎﻋﻞ اﻟﺴﻠﻴﻦ ﺑﻴﻦ اﻟﻄﻼب ﻋﺎﻟﻴﺔ وذﻟﻚ ﻧﺴﺒﺔ ﻟﻠﺘﺤﺼﻴﻦ
  %.2.3  آﺎﻧﺖ ﻋﺎﻟﻴﺔ ﺑﻴﻦ اﻟﻌﺎﻣﻠﻴﻦ( اﻟﻤﺮض) اﻳﺠﺎﺑﻴﺔ اﻟﺒﻠﻐﻢ
وﻟﻢ ﺗﻮﺟﺪ ﻋﻴﻨﺔ ﻣﻮﺟﺒﺔ ﺑﻴﻦ  (%7.9) ﻋﻴﻨﺔ ﻣﻦ اﻟﻌﻴﻨﺎت  إﻳﺠﺎﺑﻴﺔ ﻓﺤﺺ اﻟﺒﻠﻐﻢ 72ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ 
 إﻟﻲ  ﺑﺎﻻﺿﺎﻓﺔ ﺗﻢ اﻟﺘﻌﺮف ﻋﻠﻲ ﺟﻤﻴﻊ اﻟﻌﺰﻻت ﺑﻮاﺳﻄﺔ ﺧﺼﺎﺋﺼﻬﺎ اﻟﺰرﻋﻴﺔ  و.اﻻﺷﺨﺎص اﻟﻤﺤﺼﻨﻴﻦ
  اﻟﻤﺘﻔﻄﺮة اﻟﺴﻠﻴﺔ وهﺬﻩ اﻟﻨﺘﻴﺠﺔ ﺗﺸﻴﺮ إﻟﻰ أن اﻧﺘﺸﺎر اﻟﺴﻞ اﻟﺮﺋﻮي  اﻟﺨﺎﺻﺔ ﻋﻠﻲ إﻧﻬﺎاﺧﺘﺒﺎرات اﻟﻜﻴﻤﻴﺎء اﻟﺤﻴﻮﻳﺔ
   ﻓﻲ ﻣﻌﺪل اﻟﻤﺮض ﺮ ﻣﺤﺼﻨﻴﻦ ﺑﻠﻘﺎح اﻟﺴﻞ وهﺬا اﻻرﺗﻔﺎع ﻏﻴوﺟﻤﻴﻌﻬﻢ% 7.9 ﻋﺎﻟﻴﺎ ﻓﻲ ﻣﺠﻤﻮﻋﺔ اﻟﺪراﺳﺔ آﺎن
 . ﺑﺎﻟﺴﻞإﺻﺎﺑﺘﻬﻢ  ﻳﺸﺘﺒﻪ أﺷﺨﺎصت  ﻣﻦ ﺬﺧأ أن ﺟﻤﻴﻊ  اﻟﻌﻴﻨﺎت إﻟﻲ  ﻳﻌﺰي
 
 
 
 
 
 
 
1 
 
                                          Introduction 
   Pulmonary tuberculosis has been recognized as a wide spread and grave 
clinical entity for many centuries. Tuberculosis is a bacterial disease caused by 
Mycobacterium tuberculosis, and occasionally by other species of Mycobacterium 
tuberculosis complex, that includes Mycobacterium bovis, Mycobacterium 
africanum ,Mycobacterium microtti and Mycobacterium canetti. Not only 
tuberculosis has been major cause of death and prolonged disability but it often 
strikes people at age of greatest vigor and promise, despite being one of the most 
intensively studied infectious disease. However, the progressive decrease in the 
incidence of tuberculosis during late 1970s led many clinician and microbiologists to 
have supreme confidence that tuberculosis was about to be conquered. In fact the 
opposite has happened. Currently the rate of morbidity and mortality are rising as 
multi-drug resistant strains of Mycobacterium species have primarily on the heel 
onset of acquired immunodeficiency syndrome (AIDS)  epidemic and the challenge 
of BCG vaccination failure in Chig Leput trial in southern  India  (Kochi,1991). 
Tuberculosis is among the top 10 causes of global mortality and morbidity (Murray 
and Lopez, 1997).  
     Recently published estimates suggest that 32% of the world's population has 
tuberculosis infection. About nine million new cases occur each year, and almost 
two million people die of tuberculosis each year (Dye et al., 1999). Over 95 % of 
new tuberculosis cases and deaths occur in developing countries (Dye, 2006). 
In the Sudan the disease is endemic and the incidence of tuberculosis is 
increasing due to malnutrition and demography of the population from endemic 
areas to big cities where socioeconomic conditions are declining, and, tuberculosis is 
considered a major public health problem in Sudan. The annual risk of infection in 
the Sudan is 1.8% (Elsony, 2000). 
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    Humans exhibit a range of responses to M. tuberculosis. The initial infection in 
tuberculin-negative individuals most often produces a self limited lesion, but 
sometimes the disease progresses presumably because of low resistance or large 
inoculum, producing initial phase of primary tuberculosis characterized by the 
formation of primary complex (Gohn focus) in the lung parenchyma and the 
draining mediestinal lymph node producing what is known as exudative lesion. In 
post-primary form of pulmonary infection, the primary complex develops into 
productive lesion characterized by granulouma formation and caseation necrosis. 
This is the most common form of clinical tuberculosis in which one or more lung 
lesions progress to caseation and cavitation and, involving the bronchial tree, create 
a case of open or infectious tuberculosis this facilitates the spread of infection to 
distant organs producing what is known as miliary tuberculosis. On the other hand, 
reactivation of tuberculosis (healed tuberculosis) is apparently due to an impaired 
immune status often associated with malnutrition, alcoholism, advanced age or 
severs stress .Immune suppressive drugs or diseases such as diabetes and 
particularly acquired immunodeficiency syndrome (AIDS) are common 
preconditions. Mycobacterium tuberculosis stimulates both cell-mediated and 
humoral immune responses but immunity to M.tuberculosis is cell-mediated in 
nature (Jenkins, 1998). In response to this altered clinical and epidemiological 
situation several changes in laboratory practice have evolved over past several years. 
    Delayed Type Hypersensitivity to tuberculin is highly specific for the tubercle 
bacilli and various related Mycobacteria. Reactivity to tuberculin appears one month 
after infection in man and persists for many years, often for life, hence the frequency 
of reactors in the population increase cumulatively with age. Although a positive 
mantoux test reveals the presence of Mycobacteria, it does not establish the presence 
of active disease on the other hand, since tubercle bacilli do not occur as commensal 
in healthy persons and their demonstration in secretion of a patient is aproof of the 
existence of tuberculosis disease, the finding of acid fast bacilli (AFB) in sputum is 
good presumptive evidence of the presence of pulmonary tuberculosis. Such 
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provisional diagnosis based to microscopic finding is of great value because the final 
identification of Mycobacteria by culture and animal inoculation takes several 
weeks. Tubercle bacilli are most commonly demonstrated in patient with open 
pulmonary lesions, and appear to be relatively scanty in sputum from patients with 
miliary tuberculosis. In more chronic or closed lesions, few tubercle bacilli are 
observed and may not be detectable microscopically though they are demonstrated 
by culture or animal inoculation.  
 Objectives 
The principle objectives of this study were as follows: 
The general objective of the present study was to determine and to evaluate the 
prevalence of human tuberculosis among out patients at Alshaab Teaching Hospital 
in Khartoum state. The specific aims were as follows: 
1. To estimate the prevalence of reactivity to purified protein derivative (PPD), 
tuberculin in patients visiting   the out patients clinic at Alshaab Teaching 
Hospital. 
2. To determine the reaction of previously vaccinated and unvaccinated 
individual to PPD. 
3. To correlate between patients age, sex, exposure to adult with tuberculosis 
and/or positive smear to positive Mantoux test and positive culture.  
4. To estimate the prevalence of tuberculosis (disease state) in patients visiting   
the out patients clinic at Alshaab Teaching Hospital. 
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CHAPTER ONE 
LITERATURE REVIEW 
1.1 Definition of tuberculosis 
 Tuberculosis is achronic granulumatous disease affecting man, many other 
mammals. Mammalian tuberculosis is caused by five closely related species, 
collectively termed M. tuberculosis complex which includes M. tuberculosis, M. 
canetti, M. bovis, M. africanum, and M. microtti (Grange, 2002). It is an infection, 
which most commonly affects the lung, where it is called pulmonary tuberculosis 
but it can also affect the central nervous system (meningitis), circulatory system 
(millary TB), genitourinary system, bones and joints where it is called 
extrapulmonary TB (Julie, 1993).Tuberculosis is one of the first secondary 
infections to be activated in human immunodeficiency virus (HIV)-positive 
individuals and during stresses of poverty, malnutrition and war (Hawken et al.,1993 
;  Ityavyar ,1988). 
1.2 Tuberculosis history 
    Consumption, king’s evil, lupus vulgaris, and phthisis are some of the more 
colorful names for tuberculosis that have been used in the last several centuries. 
Archeological findings from a number of Neolithic sites in Europe and sites from 
ancient Egypt to the Greek and Roman empires show evidence of a disease 
consistent with modern tuberculosis (Barun et al., 2006). 
  Tuberculosis has been present in humans since antiquity. The earliest 
unambiguous detection of Mycobacterium tuberculosis is in the remains of bison 
dated 17,000 years ago (Rothschild et al., 2001). However, whether tuberculosis 
originated in cattle and then transferred to humans, or diverged from a common 
ancestor, is currently unclear (Pearce, 2006). Skeletal remains show prehistoric 
humans (4000 BC) had TB, and tubercular decay has been found in the spines of 
Egyptian mummies from 3000-2400 BC (Zink et al., 2003). At the end of the 19th 
century, Robert Koch discovered M. tuberculosis as the causative agent of TB and 
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attempted to develop a therapy using a sterile filtrate from in vitro cultures of the 
pathogen (Rook and Stanford, 1996). 
1.3 Epidemiology 
1.3.1 Global epidemiology of tuberculosis 
 Tuberculosis is a global emergency. One third of the world's population is 
infected, and although only about 5–10% develops active disease during the first few 
years following exposure (Kochi, 1991). Tuberculosis is one of the most important 
health problems in developing countries and, as infection with human 
immunodeficiency virus (HIV) becomes more prevalent, it  is becoming a serious 
problem in developed countries as well (Styblo ,1989).  M. tuberculosis is 
responsible for some eight million new illnesses and three million deaths per year; 
mostly in developing countries (Hawken et al., 1993). 
 In 1999, a total of 3,689,822 new cases of TB were reported to the World 
Health Organization (WHO), which estimated that this figure actually represented 
less than half of the actual cases in the world. In the great majority of countries, 
particularly those with low or middle incomes, over 95 % of new tuberculosis cases 
and deaths occur (Dye, 2006). The highest incidence and number of deaths occur in 
Asia and sub-Saharan Africa (WHO, 2002). The distribution of TB by countries also 
differs within the same region. Thus, for a number of years it has been estimated that 
80% of the global TB burden is concentrated in 23 countries (José  and Caminero, 
2004). 
1.3.2 Tuberculosis in Africa 
In Africa, the incidence rate has been increasing since 1990 both in countries 
with low HIV rates and in countries with high HIV rates. In 2003, the estimated 
number of new TB cases on this continent exceeded 2 millions, with almost 600,000 
deaths.  Furthermore, according to WHO, HIV prevalence in TB cases goes beyond 
50% in South Africa and 30 to 40% of TB patients who die present a TB-HIV 
conifection (Godreuil  et  al., 2007).The case fatality rate has exceeded 50 % in some 
African countries where HIV infection rates are high (De et al., 1992). In Africa, at 
                                        6
least one third of the population is already infected with M. tuberculosis. Poverty, 
AIDS and poor general health status have shifted the odds in favour of TB (WHO, 
2001).According to a study done by the U.S. Centers for Disease Control and 
Prevention. Tuberculosis case rate rose markedly in sub-Saharan Africa after 1985 
reversing a downward trend that had taken place in many countries since the late 
1970s (Cantwell and Birkin, 1996). 
1.3.3 Tuberculosis in Sudan 
       Tuberculosis is a major public health problem in Sudan. It accounts for 11.6% 
of hospital admissions in Sudan. TB is one of the most common causes of hospital 
deaths. The annual risk of infection in Sudan is 1.8%, which is corresponds to 90 
cases of smear positive tuberculosis per 100.000 populations. This would correspond 
to just over 25,000 smear positive cases each year (Elsony, 2000). In a population of 
35.522.988  in Sudan, this would correspond to just over 34 thousand smear positive 
cases each year (WHO, 2006).  The national tuberculosis program in northern Sudan 
has had success in recent years in expanding coverage of DOTS, although only 40% 
of estimated cases are detected. In southern Sudan, tuberculosis programs are 
presently limited, covering perhaps 25% of the population (World Bank, 2003). 
1.3.3.1Sudan National Tuberculosis Program 
  The National Tuberculosis Program was established in 1974 at which time“ Chest 
Unit” were created in hospitals. The treatment of tuberculosis was hospital based 
until 1990. The WHO carried out formal reviews of the TB program in 1989 and in 
1990. A manual in accordance with IUATLD and WHO approved criteria for 
national policies and procedures was published in 1990 and acentral unit was 
established in 1993 (National Tuberculosis Program, 2004). In 2001, the TB 
program was being implemented in 22 States (out of 26). The case detection rate 
was low for many years until improving in the 1990’s. According to official 
figures, about 11,000 smear-positive TB cases were detected in 2001, compared 
with less than 1,000 cases in 1993, but showing almost no change since 1997. It is 
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officially estimated that 40% of all smear positive cases are detected (World Bank, 
2003). 
1.3.3.2 Directly Observed Treatment Strategy (DOTS) 
        The (DOTS) was introduced in model areas in each state in 1996 and was 
gradually expanded. DOTS ALL OVER were declared in the year 2004. The rapid 
assessment of the national TB (NTP) conducted 2006 showed that no health facility 
is complying with DOTS component of strategy. Improve coverage of TB–DOTs 
services (high quality diagnosis and patient-centered treatment) to all existing public 
and NGOs PHC units (part of essential package of primary health care). 
1.4 Classification of mycobacterium  
Many classifications have been proposed for mycobacterium in the last 50 years. 
The classification based on major phenotypic features (growth rate and pigmentation 
type) still remains popular. As usual, the distinction between rapid and slow growth 
is based on the ability of strains to develop clearly visible colonies in less or more 
than 7 days, respectively (Runyon, 1959). Two major periods may be distinguished 
in prokaryotic taxonomy, one characterized by the utilization of phenotypic studies 
and one characterized by a focus on genotypic characteristics. In mycobacterial 
taxonomy the first period lasted from the dawn of mycobacterial studies in the late 
1880s to the end of the 1980s and the second started during the last decade of the 
20th century and has continued to the present. The rationale of genotypic taxonomy 
is linked to the detection, within the genome, of highly conserved regions harboring 
hypervariable sequences in which species-specific deletions, insertions, or 
replacements of single nucleotides are present. The gene encoding the 16S rRNA has 
been for many years, and still is, the primary target of molecular taxonomic studies, 
with several other genomic regions playing a minor role. Although the role of 
genetics has been preeminent in the recent advancement of mycobacterial taxonomy, 
an important contribution has also been made by chemotaxonomic investigations. 
This approach achieved excellent results with mycobacteria to the presence in their 
cell wall of an unusually heavy lipid burden which includes unique molecules such 
                                        8
as mycolic acids. As a consequence of these two developments, the number of 
mycobacterial species has greatly increased in the last decade (Enrico, 2003). 
1.4.1The genus Mycobacterium  
 The causative agent of infectious tuberculosis is M. tuberculosis, a rod-shaped 
obligate aerobic bacillus, which is shielded by a unique wax-rich cell wall, 
composed of long-chain fatty acids, glycolipids and other components (Kaufmann, 
2001). The genus Mycobacterium consists of more than 80 different species of 
organisms, all of which appear similar on acid-fast staining. More than half of them, 
both saprophytes and M. tuberculosis may be isolated from humans (American 
Thoracic Society, 1997). 
1.4.1.1 M. tuberculosis complex 
          Mycobacterium tuberculosis can be classified to the branch of obligate 
pathogenic, slow growing mycobacterium with a generation time of 20 to 24 hours. 
M. tuberculosis is further assigned to the M. tuberculosis complex. The M. 
tuberculosis complex includes beside M. tuberculosis, the closely related species M. 
bovis (the bovine tubercle bacillus) and its avirulent derivative M. bovis, M. microtti 
,M. canetti (subspecies of M. tuberculosis) and M.africanum (Brosch et al., 2002). 
 1.4.1.1 1 M .tuberculosis                                                                                              
          Mycobacterium tuberculosis is the most common cause of human tuberculosis 
(Acha and Szyfres, 1987) M. tuberculosis is an important human pathogen 
responsible for 3.1 million deaths worldwide per year (Dannenberg,  1994). 
1.4.1.1.2 M. bovis 
The host range of M. bovis is broad, can cause disease in a wide range of 
domestic or wild animals like cattle or goats as well as  in humans, whereas M. 
tuberculosis is the major cause of human tuberculosis (Wayne and  Kubica, 1986). 
In humans, M. bovis is the major cause of extra-pulmonary tuberculosis (Bonsu and 
Akanmori, 2001).  
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1.4.1.1.3 M. canetti 
Mycobacterium canetti is a very rare, smooth variant of M. tuberculosis and is 
usually isolated from patients from, or with connection to, Africa. Although it shares 
identical 16S rRNA sequences with the other members of the M. tuberculosis 
complex, M. canetti strains differ in many respects, including polymorphisms in 
certain house-keeping genes, (Brosch et al., 2002). 
1.4.1.1.4 M. microtti 
       Infection due to M. microtti has recently been described in humans, mainly 
immunosuppressed subjects. M. microtti strains were isolated in the 1930s from 
voles. And more recently  from immuno-suppressed patients (Brosch et al., 2002). 
1.4.1.1.5 M. africanum 
     Mycobacterium africanum consists of several strains midway between M. 
tuberculosis and M. bovis and is found in equatorial Africa.  M. africanum is 
predominantly isolated in different parts of Africa (Grange, 2002). M. africanum is 
in turn responsible for a smaller number of TB cases in Africa, owing possibly to its 
lesser virulence. (José and Caminero, 2004)  In certain areas of the continent, it is 
thought to produce a significant proportion of the cases of pulmonary TB 
(Frothingham et al., 1999; Haas et al., 1997) 
1.4.3 Environmental opportunistic mycobacteria 
Environmental opportunistic mycobacteria are distinguished from the 
members of the M. tuberculosis complex and M. leprae by the fact that they are not 
obligate pathogens but are true inhabitants of the environment. They can be found as 
saprophytes, commensals, and symbionts. Environmental mycobacteria include both 
slow-growing (i.e., colony formation requires 7 days or more) and rapidly growing 
(i.e., colony formation in less than 7 days) species. Infections with these organisms 
frequently occur in persons who have some form of immunodeficiency (e.g., HIV-
infection) or other chronic antecedent illness (CDC, 2005). M. avium complex and 
M. kansasii (usually associated with pneumonia or disseminated infection) are the 
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leading causes of nontuberculous mycobacterial infections in humans (Davies, 
1994).  
1.5 Transmission 
Tuberculosis spreads from person to person through the air by droplet nuclei, 
particles 1 to 5µm in diameter that contain M. tuberculosis complex (Edwards et al., 
1986). Droplet nuclei are produced when persons with pulmonary or laryngeal 
tuberculosis cough, sneeze, speak, or sing. They also may be produced by aerosol 
treatments, sputum induction, aerosolization during bronchoscopy, and through 
manipulation of lesions or processing of tissue or secretions in the hospital or 
laboratory (Riley, 1993). It may also result from the swallowing of organisms from 
hands or feeding utensils contaminated by the bacterium from an infected person. 
Indiscriminate spitting can contribute to transmission since sputum from infected 
persons often contains infectious bacilli (Sepkowitz et al., 1995). M. bovis may 
penetrate the gastrointestinal mucosa or invade the lymphatic tissue of oropharynx. 
It is ingested with contaminated milk containing large number of organisms (Reilly, 
1995). Air-borne transmission of M. bovis can also occur (Dankner et al., 1993). TB 
transmission occurs almost exclusively from human to human, a prerequisite is 
having contact with a source case. More than 80% of new TB cases result from 
exposure to sputum smear-positive cases, although smear-negative, culture-positive 
cases can be responsible for up to 17% new cases (Daley et al., 1999). Congenital 
TB is considered a rare event in the whole spectrum of TB presentations. This 
infection is caused by lymphohematogenous spread during pregnancy from an 
infected placenta or aspiration of contaminated amniotic fluid (Correa, 1997). 
1.6 Pulmonary tuberculosis 
Cough is the most common symptom of pulmonary tuberculosis. Early in the 
course of the illness it may be nonproductive, but subsequently, as inflammation and 
tissue necrosis ensue, sputum is usually produced and is a key to most of our 
diagnostic methods. Hemoptysis may rarely be a presenting symptom but usually is 
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the result of previous disease and does not necessarily indicate active tuberculosis. 
Hemoptysis may result from residual tuberculous bronchiectasis, rupture of a dilated 
vessel in the wall of a cavity (Huseby et al., 1976;  Grzybowski  et al., 1971).
 Droplet nuclei containing tubercle bacilli may reach the respiratory 
bronchioles or alveoli after inhalation. Establishment of infection depends on the 
interplay between the host immune system and the pathogen virulence. When 
infection occurs, the tubercle bacilli may spread through the lymphatic system and 
the blood stream to distant organs before cellular immune response takes place (Tai 
et al., 2006). 
1.6.1Primary infection 
Primary infection by tubercle bacilli induces immune and non-immune 
inflammatory reactions. Production of humoral antibodies is not the major kind of 
immunological defense in tuberculosis rather, cellular are sole tool for protection   
delayed hypersensitivity, increased macrophage activity, and granulomatous 
inflammation. The granulomatous reaction is an immune response that limits the 
dissemination of the organisms. The first exposure of the host to the tubercle 
bacillus may be completely asymptomatic, with a small (Ghon focus) of 
inflammation seen in the lung (Julie, 1993). 
Primary pulmonary tuberculosis is more common in children. It involves the 
lung and the regional lymph nodes, forming the primary complex. About 85% to 
90% of patients with primary complex heal spontaneously, whereas 10% to 15% 
progress to disease. Infected individuals are mostly asymptomatic and a positive 
tuberculin skin test may be the only evidence of infection (Stead et al., 1968). Most 
infections with M. tuberculosis are caused by inhaling droplets or dust particles 
containing the bacilli and  the site of infection usually the lung (Monica, 2002). The 
bacilli engulfed by alveolar macrophage where they replicate to form initial lesion 
(Ghon Focus),which is referred to primary tuberculosis infection, within  10 days 
post  infection. Clones of antigen specific T lymphocytes are activated. These 
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release cytokines, interferon γ which activate macrophage and cause them to form 
compact cluster or granuloma around the foci of the infection. The center of the 
granuloma contains a mixture of necrotic tissue and dead macrophage which 
undergo caseation forming cheese like appearance in consistency (Grange, 2002). 
Although M. tuberculosis bacilli are postulated to be unable to multiply within this 
caseous tissue due to its acidic pH, the low availability of oxygen, and the presence 
of toxic fatty acids, some organisms may remain dormant but alive for decades. The 
strength of the host cellular immune response determines whether an infection is 
arrested here or progresses to the next stages which cause post-primary disease 
(Dannenberg and Rook, 1994 ).The lesion becomes quiescent and surrounding 
fibroblast producing dense scar tissue which may become calcified (Grange, 2002). 
1.6. 2 Excavations and cavity formation   
In primary tuberculosis occurring as a result of recent infection, the process is 
generally seen as middle or lower lung zone infiltrate. Atelectasis may result from 
compression of airways by enlarged lymph nodes. This manifestation is more 
common in children. If the primary process persists beyond the time when specific 
cell-mediated immunity develops, cavitation may occur (so-called “progressive 
primary” tuberculosis) (Grzybowski et al., 1971). Tuberculosis that develops as a 
result of endogenous reactivation of latent infection usually causes abnormalities in 
the upper lobes of one or both lungs. Cavitation is common in this form of 
tuberculosis. The most frequent sites are the apical and posterior segments of the 
right upper lobe and the apical posterior segment of the left upper lobe. Healing of 
the tuberculous lesions usually results in development of a scar with loss of lung 
parenchymal volume and, often, calcification (Stead et al., 1968). 
1.6. 3 Post primary tuberculosis 
      Post-primary TB is usually caused by reactivation of endogenous infection rather 
than by a new, exogenous reinfection. More specifically, it has been argued that, in 
countries with low incidence of TB a combination of host immunity and limited 
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exposure to Mycobacterium tuberculosis made endogenous reactivation a more 
plausible explanation for recrudescence of disease (Vynnycky and Fine 1997).           
           Reactivation may occur when the immunity of the host is diminished. Apical 
portions of the lungs are the commonest sites of involvement. Symptoms may be 
constitutional, such as fever, malaise and weight loss, or respiratory, in particular 
chronic cough and blood-streaked sputum (Tai et al., 2006). 
  In persons with efficient cell-mediated immunity, the infection may be 
arrested permanently at latent. The granulomas subsequently heal, leaving small 
fibrous and calcified lesions. However, if an infected person cannot control the 
initial infection in the lung or if a latently infected person's immune system becomes 
weakened by immunosuppressive drugs, HIV infection, malnutrition, aging, or other 
factors, the granuloma center can become liquefied by an unknown process and then 
serves as a rich medium in which the M. tuberculosis revived bacteria can replicate 
in an uncontrolled manner. At this point, viable M. tuberculosis can escape from the 
granuloma and spread within the lungs (active pulmonary TB) and even to other 
tissues via the lymphatic system and the blood as miliary or extrapulmonary TB 
(Dannenberg and Rook, 1994). 
1.6. 4 Extra pulmonary tuberculosis 
      Tuberculosis can involve any organ system in the body. While pulmonary 
tuberculosis is the most common clinical manifestation, extrapulmonary tuberculosis 
is also an important clinical problem. The bacilli can spread from the initial site of 
infection in the lung through the lymphatics or blood to other parts of the body and 
cause extrapulmonary tuberculosis of the pleura, lymphatics, bone, genitourinary 
system, meninges, peritoneum, or skin. Before the HIV pandemic, and in studies 
involving immunocompetent adults, it was observed that extra pulmonary TB 
constituted about 10-20% of all cases with TB (Fanning, 1999; Weir and Thornton, 
1985).  
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1.6.5 Latent tuberculosis infection 
      Latent tuberculosis is where a patient is infected with M. tuberculosis, but does 
not have active tuberculosis disease. Patients with latent tuberculosis are not 
infectious, and it is not possible to get TB from someone with latent tuberculosis. 
The main risk is that approximately 10% of these patients will go on to develop 
active tuberculosis at a later stage of their life. (Sutherland, 1976; Comstock et al., 
1974). The identification and treatment of people with latent TB is an important part 
of controlling this disease (WHO, 1996).  
1.7 Antigenic structure of Mycobacteria                                                                                 
      The cell wall of Mycobacterium species is rather complex and consists of three 
major structures, the cytoplasmic membrane, the outer layer and the capsule-like 
structure. The peptidoglycan layer is covered by extensively branched 
arabinogalactan. Arabinogalactan is composed of a linear galactofuran connected to 
the rhaminified element, the arabinofuran. Mycolic acids, long-chain α-branched β-
hydroxy fatty acids, are in turn covalently linked to the arabinogalactan and are 
orientated perpendicular to the cytoplasmic membrane (Brennan  and  Nikaido, 
1995; Minnikin, 1991). Mycobacterial strains contain a mixture of different mycolic 
acid species. Peptidoglycan, arabinogalactan and mycolic acids together form the 
cell wall core. By hydrophobic interactions, free lipids such as phospholipids, 
glycopeptidolipids and lipooligosaccharides are attached to the mycolic acids 
forming the outer lipid layer (Fig.1.1). M.tuberculosis possesses a cell wall 
dominated by covalently linked mycolic acids, D-arabino-D-galactan, and 
peptidoglycan, the mycolic acids of which are complemented by glycolipids  such as 
trehalose dimycolate (cord factor) and trehalose  monomycolate. This mycolic acid-
based permeability barrier shields the organism from environmental stress and 
contributes to disease persistence and the refractoriness of   M. tuberculosis to many 
antibiotics (Brennan and Nikaido, 1995). The cell wall of Mycobacteria contains 
peptidoglycan similar to that of the other Gram-positive organisms except that it 
contains N-glycolylmuramic rather than N-acetylmuramic acid. Attached to 
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peptidoglycan are a myriad of branched chain polysaccharides, protein and lipid of 
articular importance are long chain fatty acids called mycolic acid for which 
mycobacteria are named, that make up to 60% of  the cell mass and are distinctive 
for each species. Other lipid component includes mycosides, sulfolipids, and 
lipoarabinomannan (LAM). LAM is structurally and functionally analogues to the 
lipopolysaccharide (James and Plorde, 2004).  
1.8 Immune response to mycobacterial infection 
1.8 .1 Innate immune responses 
Besides phagocytosis, recognition of M. tuberculosis or mycobacterial 
products is crucial for an effective host response. Phagocytic cells play an important 
role in the initiation and direction of the adaptive immunity by presentation of 
mycobacterial antigens and expression of co-stimulatory molecules and cytokines. 
Central to immune defence against microbial pathogens are pattern recognition 
receptors such as the Toll-like receptors (TLRs). Emerging evidences suggest that 
TLRs play an important role in the activation of immune cells by pathogens, 
including M. tuberculosis (Bulut et al., 2001 and  Hajjar et al., 2001). 
Predominantly, a role for TLR2 in immune recognition of M. tuberculosis has been 
demonstrated. Mycobacterial products have been demonstrated to induce secretion 
of tumor necrosis factor-α (TNF-α) and nitric oxide (NO) by macrophages via 
interaction with TLRs, as well as inducing apoptosis in the host cell (Aliprantis et 
al., 1999; Brightbill et al., 1999).When bacilli are engulfed by alveolar acrophages, 
local chemokine signals attract other macrophages from local tissues, from 
lymphatics in the bronchial tree, and from the blood (Cooper et al., 1993; Cooper et 
al., 1995; Flynn et al., 1993; Orme et al., 1993) 
1.8 .2 Adaptive immune response against M. tuberculosis  
In contrast to innate mechanisms, the specific or adaptive immune response 
requires the specific recognition of foreign antigens. The innate immune system has 
a profound influence on the type of acquired immune mechanisms generated, and 
vice versa, the specific immune response executes several of its effector functions 
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via the activation of components of the innate immunity. Specific immune responses 
can be divided into cell-mediated mechanisms, which include T-cell activation and 
effecter mechanisms, and the humoral immune response, consisting of B-cell 
maturation and antibody production. Both mechanisms are not mutually exclusive, 
and T helper cells are required for antibody maturation, isotype switching and 
memory. B cells also function as antigen presenting cells by activating T cells in a 
specifically driven manner (Collins and Kaufman, 2002).  
Mycobacterium tuberculosis is the most conspicuous example of an intracellular 
bacterium that persists for long periods within the host, causing a latent infection, 
namely, a chronic asymptomatic infection without tissue damage. This is best 
illustrated by the fact that two billion people worldwide are infected with M. 
tuberculosis, but more than 90 % of them remain healthy and free of clinical disease 
and the tubercle bacilli remain within them in a state of dormancy. Therefore, 
although the host cell-mediated immunity is enough to control the progression of 
disease, it fails to exert sterile eradication and hence, those two billion infected 
persons suffer the latent form of TB (Collins and Kaufman, 2002). As for other 
intracellular infections, the primary protective immune response is cell mediated 
rather than antibody mediated. M. tuberculosis resides inside the macrophage and is 
relatively resistant to microbicidal mechanisms that efficiently eliminate other 
phagocytosed bacteria. This is due in part to the ability of the tubercle bacilli to 
hinder macrophage activation by IFN-γ and IL-12 (Jouanguy et al., 1999; Alcais et 
al., 2005) 
1.8.2.1 Humoral immune response 
  Because of their intracellular location, tubercle bacilli are not exposed to antibody 
and therefore this type of immune response is considered to be non-protective. 
However, during the initial steps of infection, antibodies alone or in conjunction 
with the propercytokines may provide important functions, such as prevention of 
entry of bacteria at mucosal surfaces. Even though the issue remains controversial, 
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the role of antibodies in intracellular bacterial infections has gained renewed 
attention. Lately, their participation in the control of acute infections, such as 
chlamydial respiratory infection (Skelding et al., 2006), and chronic infections 
produced by Actinomycetes, including M. tuberculosis (Salinas and Perez, 2004; 
Williams et al., 2004; Reljic et al., 2006).Antibodies could enhance immunity 
through many mechanisms including neutralization of toxins, opsonization, 
complement activation, promotion of cytokine release, antibody-dependent 
cytotoxicity, and enhanced antigen presentation. In this sense, data from several 
laboratories indicate that anti-mycobacterial antibodies play an important role in 
various stages of the host response to TB infection (Costello et al., 1992; Hoft et al., 
1999; Hoft et al., 2002; Teitelbaum et al., 1998; Williams et al., 2004; De et al., 
2005).This enhanced anti-mycobacterial activity of phagocytes by antibody-coated 
bacilli is extremely important in the context of mucosal immunity. IgG and IgA 
antibody classes have been shown to be present in the mucosal secretions of the 
human lower respiratory tract (Boytonand and  Openshaw, 2002).The specific 
mycobacterial targets for antibody-mediated enhanced interiorization and/or killing 
are not known, but surface antigens such as LAM or proteins expressed under stress 
conditions, such as alpha crystallin protein, may be relevant. In an experiment where 
17 recombinant mycobacterial protein antigens, native Ag85 complex, LAM, and M. 
tuberculosis lysate were used to detect antibody responses induced by BCG 
vaccination (Brown et al., 2003). 
1.8 .2.2 Cellular immune response 
Since the tubercle bacilli reside inside a compartment within the macrophage, 
their antigens are presented by MHC class II molecules to CD4+ T lymphocytes. 
These cells play an important role in the protective response against M. tuberculosis 
and, when they are absent, growth of the bacilli cannot be controlled (Caruso et al., 
1999; Muller et al., 1987). This is the case in patients with an immunodeficiency, 
such as that caused by HIV infection. The main function of CD4+ T cells is the 
production of cytokines including IFN-γ, which activates macrophages and promotes 
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bacilli destruction. Recently, another function has been ascribed to these cells, i.e., 
helping to develop the CD8+ T cell- mediated response (Scanga et al., 2000; Serbina 
et al., 2001). In addition, CD8+ T cells proved to be efficient in lysing infected cells 
and in reducing the number of intracellular bacteria (Stenger,et al 1997 and Cho et 
al.,2000) Presentation of mycobacterial antigens by macrophages and dendritic cells 
involve distinctive mechanisms. First, MHC class II molecules present 
mycobacterial proteins to antigen specific CD4+ T cells. These antigens must be 
processed in phagolysosomal compartments in professional antigen-presenting cells. 
Second, MHC class I molecules, expressed on all nucleated cells, are able to present 
mycobacterial proteins to antigen-specific CD8+ T cells. This mechanism allows for 
the presentation of cytosolic antigens, which may be important as certain 
mycobacterial antigens may some how escape from the phagosome (Mazzaccaro et 
al., 1996). The importance of MHC class I-mediated antigen presentation has been 
shown in murine models (Sousa et al., 2000) and tuberculosis patients (Cho et 
al.,2000 and Geluk et al., 2000).Third, nonpolymorphic MHC class I molecules such 
as type I CD1 (-a, -b, and -c) molecules, which are expressed on macrophages and 
dendritic cells, are able to present mycobacterial lipoproteins to CD1- restricted T 
cells. This mechanism of antigen presentation enables the activation of a larger 
fraction of T cells at an earlier point in the infection, before antigen specificity has 
developed (Lewinsohn et al., 1998). 
        The M. tuberculosis is a classic example of a pathogen for which the protective 
immune response relies on cell mediated immunity. The initial interactions in the 
lungs is with alveolar macrophages, but after this first encounter dendritic cells and 
monocyte-derived macrophages, recruited to the site of infection, also take part in 
the phagocytic process (Henderson et al., 1997; Thurnher et al., 1997). Infected DCs 
mature and migrate to draining lymph nodes to prime naive T cells via processed 
antigens. Inflammation in the lungs provides the signals that direct the effector T 
lymphocytes back to the site of infection where granulomas are formed. The 
anatomic affinity of these cells appears to be mainly determined by site-specific                      
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Fig. 1.1: Mycobacterial cell Wall. The cell wall of mycobacteria consists of 
three layers: the cytoplasmic membrane, the outer lipid layer and the capsule 
(Tonge, 2000). 
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integrins, “homing receptors”, on their surface and complementary mucosal tissue-
specific receptors, “addressins”, on vascular endothelial cells (Kunkel and Butcher, 
2003). In addition, chemokines produced in the local microenvironment promote 
chemotaxis toward mucosal tissues and regulate integrin expression on mucosal 
lymphocytes, thereby controlling cell migration  and generation of activated  
macrophage (Champbell et al., 2003). 
1.8.3 Granuloma formation  
A tuberculous granuloma is observed concomitant with a highly activated 
cell-mediated immune response, which generally mediates control the numbers of 
mycobacterial in the lungs (Gonzales et al., 2001). Granuloma formation is the 
hallmark of M. tuberculosis infection. Granulomas are formed in response to chronic 
local antigenic stimulation, and can be observed in different infectious diseases, 
including schistosomiasis, leprosy, and leishmaniasis (Reyes, 1986; Modlin and Rea, 
1988; Palma and Saravia, 1997; Rumbley and Phillips, 1999; Boros, 1999). 
Structure and composition of granulomas vary depending on the organism. The 
granuloma is composed of many different cells, including macrophages, CD4+, and 
CD8+ T cells, and B cells (Gonzales et al., 2001). These cells control the infection 
by providing a local environment for the cells to interact, leading to an effective 
immune response where cytokine production, macrophage activation and CD8+ T 
cell-effector functions lead to killing of the mycobacteria. Granulomas also provide 
a way of containing the bacilli by walling off and preventing spread of infection. 
Altogether these actions lead to inhibition of growth, or death of M. tuberculosis. 
However, the resulting pathology can cause additional problems for the host. 
Elimination of M. tuberculosis infection mainly depends on the success of the 
interaction between infected macrophages and T lymphocytes. Primary as well as 
acquired immunodeficiencies, especially human immunodeficiency virus infection, 
have dramatically shown the importance of cellular immunity in tuberculosis. CD4 
T cells exert their protective effect by the production of cytokines, primarily gamma 
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interferon (IFN-γ), after stimulation with mycobacterial antigens. Other T-cell 
subsets, like CD8T cells, are likely to contribute as well, by secreting cytokines and 
lysing infected cells (Geluk et al., 2000 ; Stenger and Modlin, 1999).  
1.8 .4Apoptosis 
Apoptosis may constitute another effector mechanism for the infected host to 
limit outgrowth of M. tuberculosis (Keane et al., 1997 and Placido et al .,  1997). 
Apoptosis of phagocytic cells may prevent dissemination of infection. In addition, 
apoptosis of infected cells reduces viability of intracellular mycobacteria, while 
necrosis of infected cells does not (Ogawa et al., 1991 and Molloy et al.,1994). 
TNF-α is required for induction of apoptosis in response to infection with M. 
tuberculosis (Keane et al., 1997). CD4+ T cells may participate in the induction of 
apoptosis of infected cells and the subsequent reduction of bacterial viability through 
the CD95 Fas ligand system (Oddo et al., 1998). 
1.8.5 Immune evasion  
Despite the preferred target cell, whose function is the elimination of microbes; 
M. tuberculosis can remain viable after phagocytosis through different strategies 
evolved to evade host immune responses. The use of certain CRs may be 
advantageous for the bacterium, since engagement of these receptors does not induce 
the release of cytotoxic reactive oxygen intermediates (Wright and Silverstein, 
1983). Moreover, it is well known that mycobacteria can evade the normal 
phagosome-lysosome fusion pathway resulting in persistence of the bacteria within 
the host cell (Armstrong and Hart, 1975). In this way the bacteria not only remain 
viable, but bacterial antigens are prevented from presentation to T cells. 
Mycobacteria appear to increase retention of a macrophage protein, termed the 
tryptophan-aspartate containing coat (TACO) protein, on the surface of the 
mycobacterial phagosome, and thereby preventing phagosome-lysosome fusion 
(Ferrari et al., 1999). In addition, expression of major histocompatibility complex II 
molecules is decreased in M. tuberculosis-infected macrophages. Another immune 
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evasion mechanism is the secretion of proteins such as superoxide dismutase and 
catalases by M. tuberculosis, which are antagonistic to reactive oxygen intermediates 
(Andersen et al., 1991). And inhibition of macrophage apoptosis (Fratazzi et al., 
1999). Macrophages infected with M. tuberculosis produce inhibitory cytokines, 
such as transforming growth factor ß1 and interleukin (IL)-10, which reduce 
macrophage activation, thereby leading to decreased clearance of bacteria (Barnes et 
al., 1992;  Toossi et al., 1995). 
1.9 Methods of diagnosis of Tuberculosis 
  1.9.1 Clinical diagnosis  
  1.9.1.1 Symptoms 
         The most important symptoms in diagnosis of pulmonary tuberculosis  are 
cough (> 3 weeks), sputum production and weight loss (WHO, 1996). Over 90% of 
patients with sputum smear-positive pulmonary tuberculosis develop a cough soon 
after disease onset. However, cough is not specific to pulmonary tuberculosis. 
Cough is common in smokers and in patients with acute upper or lower respiratory 
tract infection. Most acute respiratory infections resolve within 3 weeks, therefore, a 
patient with a cough for more than 3 weeks, a pulmonary tuberculosis is suspected 
and the patients must submit sputum for diagnostic microscopy (WHO, 1996). 
Patients with pulmonary tuberculosis may also have other symptoms; these may be 
respiratory haemoptysis, chest pain, breathlessness, fever, night sweats, tiredness 
and loss of appetite (general or systemic). Weight loss and fever are more common 
in HIV-positive pulmonary tuberculosis patients than in those who are HIV-
negative. Conversely, cough and haemoptysis are less common in HIV-positive 
pulmonary tuberculosis patients than those who are HIV-negative. This is probably 
because there is less cavitation, inflammation and bronchial irritation in HIV-
positive patients (WHO, 1996). 
1.9.1. 2 X- ray 
The chest x-ray is useful for diagnosing TB disease because about 85% of TB 
patients have pulmonary TB (TB disease in the lungs). Usually, when a person has 
TB disease in the lungs, the chest x-ray appears abnormal. It may show infiltrates 
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(collections of fluid and cells in the tissues of the lung) or cavities (hollow spaces 
within the lung that may contain many tubercle bacilli). However, the results of a 
chest x-ray cannot confirm that a person has TB disease. A variety of illnesses may 
produce abnormalities whose appearance on a chest x-ray resembles TB. Although 
an abnormality on a chest x-ray may lead a clinician to suspect TB. Moreover, a 
chest x-ray cannot detect TB infection (Grzybowski et al., 1971). Chest radiographs 
in patients with bacteriologically proven pulmonary TB appear normal in a minority 
of patients; however, this occurs more often in the presence of HIV infection 
(Korzeniewska-Kosela et al., 1992). 
1.9.2 Microbiological Tests  
Microbiological tests, together with radiological investigations, are the key 
investigative tools used in the diagnosis of TB. Sputum for acid fast bacilli (AFB) 
direct smear and culture examination should be performed as part of the initial 
investigations of choice for patients with suspected pulmonary TB. Other clinical 
samples for microbiological diagnosis include gastric washing, bronchial aspirate, 
pleural fluid, biopsy specimens of the lung, or non-respiratory specimens like early 
morning urine, lymph node aspirate, pericardial fluid, cerebrospinal fluid, joint fluid, 
etc. Although a range of laboratory diagnostic tests are available, the basic tests 
include strain identification and drug susceptibility test for positive culture isolates 
apart from direct microscopy and culture (Tam et al., 2006). 
1.9.2 .1Collection of Specimens for Demonstration of Tubercle Bacilli  
      Because the identification of organisms is so critical in diagnosing tuberculosis, 
it is of utmost importance that careful attention be given to the collection and 
handling of specimens. For optimal results, specimens should be collected in clean, 
sterile containers and held under conditions that inhibit growth of contaminating 
organisms, since most specimens will contain bacteria other than mycobacteria. 
Because mycobacterial disease may occur in almost any site in the body, a variety of 
clinical materials may be submitted to the laboratory for examination. All specimen 
collection procedures that produce aerosols that potentially contain M. tuberculosis 
                                        24
should be performed in properly ventilated areas or safety cabinets by per- sonnel 
using adequate respiratory protection (Decker, 1993; Willeke and Qian, 1998). The 
common specimens, such as sputum patients needs to be instructed as to the proper 
method of sputum collection. It is important that the patient be informed that 
nasopharyngeal discharge and saliva are not sputum; rather, the material brought up 
from the lungs after a productive cough constitutes the material desired. Whenever 
possible, attending personnel should observe the sputum collection. A series of at 
least three single specimens (but usually not more than six) should be collected 
initially (preferably on different days) from sputum-producing patients. For optimal 
results, sputum should be collected and processed in the same container. 
Commercially available sputum collection devices using a 50-ml plastic, single-use, 
disposable centrifuge tube is recommended (Dufour, 1993). For patients who have 
difficulty in producing sputum, there are several methods of obtaining a specimen. 
Inhalation of an aerosol of sterile hypertonic saline (3–15%), usually produced by an 
ultrasonic nebulizer, can be used to stimulate the production of sputum (Shinnick 
and Good, 1995). Even though aerosol-induced specimens may appear thin and 
watery, they should be processed. The specimen should be clearly labeled as induced 
sputum so it will not be discarded by the laboratory as an inadequate specimen. 
Because the cough induced by this method may be violent and uncontrolled, patients 
should be in areas with adequate environmental controls such as a hood or booth 
fitted with a high-efficiency particulate air (HEPA) filter to prevent transmission. 
They should be attended by qualified personnel using appropriate respiratory 
protection (CDC, 1994). 
1.9.2.2 Staining and Microscopic Examination 
 The detection of acid-fast bacilli in stained smears examined microscopically is 
the first bacteriological evidence of the presence of mycobacteria in clinical 
specimens. Acid-fast staining procedure depends on the ability of mycobacteria to 
retain dye when treated with mineral acid or an acid-alcohol solution. Smear 
examination is rapid, inexpensive, technically simple, and highly specific for acid-
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fast bacilli, such as M. tuberculosis (American Thoracic Society, 2000) and it 
provides the physician with a preliminary confirmation of the diagnosis. Also, 
because it gives a quantitative estimation of the number of bacilli being excreted, the 
smear is of vital clinical and epidemiologic importance in assessing the patient’s 
infectiousness. Smears may be prepared directly from clinical specimens or from 
concentrated preparations. Two procedures are commonly used for acid–fast 
staining: the carbolfuchsin methods, which include the Ziehl–Neelsen and Kinyoun 
methods, and a fluorochrome procedure using auramine- O or auramine–rhodamine 
dyes. Several quantitative studies have shown that there must be 5,000 to 10,000 
bacilli per milliliter of specimen to allow the detection of bacteria in stained smears 
(Hobby et a1., 1973). The percentage of specimens shown positive by smear but 
negative in culture should be less than 1% (Lipsky et al., 1984). The sensitivity of 
sputum smear microscopy has been reported to be between 22-80% of culture-
confirmed tuberculosis (Colebunders and Bastian, 2000). Acid-fast bacilli are 
approximately 0.2 – 0.8 x 1 – 10 µm and appear as slender, straight, curved or bent. 
With carbolfuchsin staining, M. tuberculosis looks as fine red rods, slightly curved, 
more or less granular, isolated, in pairs or in groups, standing out clearly against the 
blue background. With fluorochrome staining, tubercle bacilli emit a bright yellow 
fluorescence against a pale yellow (potassium permanganate) or orange (acridine 
orange) background. Some mycobacteria other than M. tuberculosis may appear 
pleomorphic, ranging in appearance from long rods to coccoid forms, with uniform 
distribution of staining properties (WHO, 1998).In reading smears, the microscopic 
examination should provide the clinician with a rough estimate of the number of 
AFB detected. Table 1 shows a frequently used scheme to quantify organisms seen 
on AFB smear (American Thoracic Society, 2000). 
1.9.2.3 Decontamination and Digestion of Specimens 
     Several methods have been used to minimize culture contamination when 
specimens from non-sterile body sites are processed. Most of these methods include 
the digestion of mucus or organic debris and treatment to eliminate micro-organisms  
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 Table.1.Quantization scale for acid-fast bacillus smears according to stain         
             used.  
               
 
 
 
 
 
 
 
 
 
 
 
             
(American Thoracic Society, 2000) 
 
 
 
 
 
 
Carbolfuchsin 
                
 
Fluorochrome 
 
 
Quantity Reported          
 
No AFB/300 fields No AFB/30 fields No AFB seen 
1–2 AFB/300 fields 1–2 AFB/30 fields  Doubtful, repeat test 
1–9 AFB/100 fields 1–9 AFB/10 fields Rare (1+) 
1–9 AFB/10 fields 1–9 AFB/field Few (2+) 
1–9 AFB/field 10–90 AFB/field Moderate (3+) 
 9 AFB/field. 
 
90 AFB/field 
 
Numerous (4+) 
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from the   normal flora. Both steps are done to maximize the probability of isolating 
mycobacteria in culture.No single decontamination method is applicable to all 
circumstances, laboratories and clinical specimens; therefore, a laboratory should 
use the best suited method that keeps the contamination rate between 3 % and 5 %.     
       A contamination rate lower than 3 % may indicate that the procedure used is 
too harsh and may be killing the mycobacteria (José and Caminero, 2004). Because 
mycobacteria are more refractory to harsh chemicals than are most other 
microorganisms, chemical decontamination procedures have been successfully 
applied to ensure the recovery of acid-fast bacteria from clinical materials. On 
arrival in the laboratory, most specimens are homogenized with a mucolytic agent 
(such as N-acetyl- L-cysteine) and decontaminant (such as a 1–2% sodium 
hydroxide solution) to render the bacterial contaminants nonviable. The mildest de-
contamination procedure that provides sufficient control of the contaminants without 
killing the mycobacteria is likely to yield the best results (Della and Writte, 1998).  
1.9.3 Cultivation of mycobacteria                                                                               
         Culture is much more sensitive than microscopy, being able to detect as few as 
10 bacteria/ml of material (Yeager et al., 1967). In general, the sensitivity of culture 
is 80—85% with, a specificity of approximately 98% (Morgan et al., 1983 and 
Ichiyama et al., 1993). Three different types of traditional culture media are 
available: egg based (Löwenstein-Jensen), agar based (Middlebrook 7H10 or 7H11 
medium) and liquid (Middlebrook 7H12). Of the solid media, growth of 
mycobacteria tends to be slightly better on the egg-based medium but more rapid on 
the agar medium (Morgan et al., 1983). A major improvement in mycobacteriology 
has been the development of commercial broth systems for mycobacterial growth 
detection. Automated culture systems such as BACTEC 460 (Becton Dickinson 
Microbiology Systems, Sparks, MD), mycobacterial growth indicator tube (MGIT) 
systems, ESP (Extra Sensing Power), Myco-ESP culture System II (Trek Diagnostic 
Systems, Inc., Westlake, OH), and BacT/ALERT MB Susceptibility Kit (Organon 
Teknika, Durham, NC), use Middlebrook 7H12 media with added material for 
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detection of mycobacteria (radiometric or colorimetric systems). Liquid systems 
allow for rapid growth [detection of mycobacterial growth within 1–3 weeks 
compared with solid media, where growth takes 3–8 weeks (Morgan et al., 1983) 
1.9.3 .1 Egg-based media 
Löwenstein-Jensen (LJ) medium is most widely used for M. tuberculosis culture. 
The modification of the International Union Against Tuberculosis and Lung Disease 
(IUATLD) is recommended and will be described in details. Löwenstein-Jensen 
medium containing glycerol favours the growth of M. tuberculosis while LJ medium 
without glycerol but containing pyruvate encourages the growth of M. bovis. Both 
should be used in countries or regions where patients may be infected with either 
organism (WHO, 1998) 
1.9.3 .2 BACTEC 460 (Becton Dickinson)  
          BACTEC System developed by Middlebrook et al. in 1977. The rapid 
radiometric culture system or BACTEC (Becton-Dickinson) has been accepted for 
the culture isolation of mycobacteria using an enriched Middlebrook 7H12 
containing 14C labeled palmitic acid. This medium is otherwise called BACTEC 
12B. Mycobacterial growth is determined by the utilization of 14C with release of 
14CO2 by the multiplying mycobacteria and is detected in an ionic chamber with 
electronic detector in the BACTEC instrument. (Laglo and Michaud 1984; Laglo 
and Handzel, 1986; Park, 1984; Takahasi and foster 1983)  
1.9.3 .3 Liquid systems 
Liquid systems allow for rapid growth detection of mycobacterial growth 
within 1–3 weeks compared with solid media, where growth takes 3–8 weeks 
(Morgan et al., 1983), whereas agar media provide an opportunity to examine 
colony morphology and detect mixed cultures. At least one container of solid 
medium should be inoculated and used in conjunction with broth culture systems. 
Growth in liquid culture systems cannot be similarly quantitated although a 
qualitative measure of organisms in the inoculum can be made by noting the time 
required for liquid culture to turn positive (American Thoracic Society,2000) 
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1.9.3 .4 Mycobacteria growth indicator tube  
         The mycobacteria growth indicator tube (MGIT) (Nippon Becton Dickinson 
Co., Ltd., Tokyo), which is a recently introduced nonradiometric culture system, 
uses an oxygen-quenched fluorescent indicator. A fluorescent compound, ruthenium 
metal complex, is embedded in silicone on the bottom of 16x100 mm round-bottom 
tubes. Actively respiring mycobacteria consume the dissolved oxygen and allow the 
fluorescence to be observed with a 365 nm UV transilluminator. The mean time for 
detection of the Mycobacterium tuberculosis complex is 16 days (Abe et al., 1992).  
1.9.3.5 Septi–Chek  
                   This is a biphasic medium system (Roche) consisting of an enriched selective 
broth and a side with nonselective Middlebrook agar on one side and with two 
sections on other side, one with p-nitro-alpha-acetylamino-beta- hydroxyl propio- 
phenone (NAP) and egg-containing agar, the second with chocolate agar for 
detection of contamination. This system has also been found to be quite useful for 
rapid detection of growth of mycobacteria (Isenberg et al., 1991).  
1.9.3.6wMB-REDOX                                                                                                             
     MB-REDOX (Biotest AG, Frankfurt, Germany) is the four milliners serum- 
supplemented, modified Kirchner medium, containing a colorless tetrazolium salt, 
special vitamin complex and the antibiotic mixture, PACT (polymixin B, 
amphotericin B, carbenicillin and trimethoprim). In this method, the tetrazolium salt 
is reduced by the redox system of the mycobacteria to a brownish formazan. This 
formazan is water insoluble and is easily detected by the naked eye. The mean time 
for confirmation of M. tuberculosis complex is 15 days for processing of the 
specimens with the MB-REDOX (Cambau et al., 1999) 
 1.9.4 Identification of Mycobacteria Directly from Clinical Specimens 
The direct detection and identification of M. tuberculosis has resulted from 
methods using nucleic acid amplification techniques. These technologies allow the 
amplification of specific target sequences of nucleic acids hat can then be detected 
through the use of a nucleic acid probe for both RNA and DNA amplification 
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systems (Cohen et al., 1998).  Nucleic acid amplification methods can be applied to 
clinical specimens within hours. These procedures can produce a positive result from 
specimens containing as few as 10 bacilli (Shinnick et al., 1995). When evaluating 
the utility of these tests, it is important to keep in mind that initial studies were 
performed from the perspective of the laboratory, not from the clinical perspective. 
In clinical respiratory specimens that are AFB smear positive, the sensitivity of the 
amplification methods is approximately 95%, with a specificity of 98%. In 
specimens that contain fewer organisms and are AFB smear negative, the nucleic 
acid amplification test is positive in 48–53% of patients with culture-positive and the 
specificity remains approximately 95% (American Thoracic Society, 1997). Thus, 
the CDC included a positive nucleic acid amplification test in the setting of a 
positive smear as confirmation of the diagnosis of tuberculosis (Catanzaro et al., 
2000)  
1.9.5 Identification of mycobacteria from culture 
     Historically, M. tuberculosis could readily be identified by its rough, 
nonpigmented, corded colonies on oleic acid–albumin agars; a positive niacin test; 
generally weak catalase activity, that is lost completely by heating to 68OC; and a 
positive nitrate reduction test. Observation of mycobacterial colonial morphology 
remains a valuable tool. Although the colonial morphologies of mycobacteria on 
various egg-based media may be quite similar, their appearance on Middlebrook 
7H10 or 7H11 agar is distinctive (Runyon, 1970). 
1.9.5.1 Biochemical tests 
  The mycobacteria comprising the M. tuberculosis complex can easily be 
differentiated using a set of biochemical tests, since these microorganisms are niacin 
positive, reduce nitrates to nitrites, and possess pyrazinamidase (which allows the 
distinction between M. tuberculosis and M. bovis) as well as a heat-sensitive 
(thermolabile) catalase. The main limitations of biochemical techniques are their 
complexity, slowness, and lack of reproducibility, although they are considerably 
less expensive than other options. These limitations have led to the development of 
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fast, alternative identification techniques, such as chromatography and genetic 
probes. However, only biochemical tests are indicated for routine application in 
countries with low or middle-income levels (José and Caminero, 2004). Selected 
biochemical tests that are commonly used in distinguishing between species of the 
genus Mycobacterium are shown in Table2. Biochemical methods can distinguish 
mycobacterial species, but are time-consuming and laborious (Shinnick et al., 1995).  
1.9.6 Polymerase chain reaction (PCR) 
         Several research tools, which are not yet used routinely in clinical settings, 
may prove useful in diagnosing TB. The polymerase chain reaction (Picken et al., 
1988) is the most promising of this group of tools. With the use of synthesized 
primers of M. tuberculosis DNA, this technique can identify organisms in samples 
with a low bacterial count (less than 10 bacilli) within a short period (24 to 48 hours) 
after collection of the sample. Its main disadvantages are its high sensitivity and the 
risk of contamination of the sample. The practical problems associated with 
polymerase-chain-reaction testing of various body secretions and tissues are rapidly 
being overcome (Fitz et al., 1991; Manjunath et al., 1991). The technique is also 
useful in distinguishing between M. tuberculosis and other mycobacteria when 
smears are positive for acid-fast bacilli. Rapid species identification is particularly 
valuable in patients with HIV infection, because most of the mycobacterial isolates 
in such atients are not M. tuberculosis (Fitz et al .,1991).The PCR is a rapid and 
powerful procedure for the in vitro generation of millions of copies of specific DNA 
segment. In the research laboratory, this procedure can produce a positive result 
from specimens containing as few as 10 bacilli (Shinnick and Good, 1995).Patients 
are not M. tuberculosis (Fitz et al .,1991).The PCR is a rapid and powerful 
procedure for the in vitro generation of millions of copies of specific DNA segment.  
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Table 2. Identification of slowly growing Mycobacteria  
 
 
Adopted from  pattyn and portaels , (1972) 
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In the research laboratory, this procedure can produce a positive result from 
specimens containing as few as 10 bacilli (Shinnick and Good, 1995).  
 1.9.7 Genotyping of Mycobacterium tuberculosis 
       Genotyping or DNA fingerprinting of M. tuberculosis has replaced phage typing 
as a method for determining the clonality of bacterial cultures. The Southern blotting 
method is used, where by cultured organisms are heat killed and their DNA is 
isolated, cut with specific restriction enzymes, separated in an agarose gel by 
electrophoresis, transferred to a membrane, and probed for specific genetic 
sequences. A standardized protocol has been developed to permit comparison of 
genotypes from different laboratories around the world (VanEmbden et al., 1993). 
Genotyping is useful in confirming laboratory cross-contamination (Dunlap et al., 
1995), investigating outbreaks of tuberculosis (Valway, 1998), evaluating contact 
investigations (Behr and Small, 1997), and determining whether new episodes of 
tuberculosis are due to reinfection or reactivation (Markowitz et al., 1993). In 
addition, genotyping is useful for elucidating sites and patterns of M. tuberculosis 
transmission within communities (Kimerling et al., 1998 ; Braden et al., 1997)   
1.10 Immunodiagnostic Tests 
A variety of immunodiagnostic tests for tuberculosis are based on recognition of 
specific host responses to the infecting organism. Historically, the first 
immunodiagnostic test was the tuberculin skin test. The shortcomings of this test 
include its inability to distinguish active disease from past sensitization and an 
unknown predictive accuracy (Snider, 1982). Until 2001, the only test used to 
diagnoses latent tuberculosis infection (LTBI) was the tuberculin skin test. However, 
in 2001 a new QuantiFERON®-TB was developed. Quantification of gamma 
interferon forms the basis of the test this test was originally developed for the 
diagnosis of cattle tuberculosis (Bellete et al., 2002). Much effort has been devoted 
to the development of serological tests for tuberculosis, but no test has found 
widespread clinical use (Bardana et al., 1973). The specifications of serological tests 
that use crude antigen preparation are too low for clinical application. Specificity 
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can be increased by using purified antigens, but since not all patients respond to the 
same antigens, the increased specificity often results in decreased sensitivity (Chan 
et al., 1990). Sensitivity and specificity remain high if ELISA results obtained with a 
set of purified antigens are combined. The antigens tested in serologic assays include 
the 38,000 antigen, the antigen 85 complex and Mycobacterial glycolipids (Jackett et 
al., 1988).   
1.10.1 Koch phenomenon. 
The earliest demonstration of immunity occurred when Koch showed that a 
second injection of tubercle bacilli into guinea Pig’s produce a different host 
response from that of   initial injection. In essence, Koch’s initial injection resulted 
in an ulcer that failed to heal at injection site followed by spread to regional lymph 
node.  
A subsequent injection several weeks later was characterized by more localized 
ulcer that eventually healed and by guinea pig’s ability to kill the tubercle bacilli 
before they reached the regional lymph nodes. This observation called Koch 
phenomenon. (Volk, 1978) .Koch found that injection of culture filtrate into an 
animal that had been previously infected with tubercle bacilli evoke allergic 
response characterized by indurations erythema and by ulcerative necrosis at the site 
of injection. Koch named that culture filtrate Tuberculin (Volk, 1978) 
1.10.2 Tuberculin test 
In 1890, about eight years after the discovery of the tubercle bacillus 
(Kaufmann, 2000; Gradmann, 2001; Gradmann, 2006). Robert Koch first prepared 
an extract from a heat-sterilised culture of M. tuberculosis through filtering and 
evaporation. The product was known as old tuberculin. Koch initially tried but failed 
to use this as a therapeutic agent. Its diagnostic value was subsequently recognized 
by Clemens von Priquet in 1907. Mantoux was the first person to introduce the 
intradermal technique, which still bears his name (Menzies, 2000). Tuberculin test is 
widely used to screen for mycobacterial infection, and is used to provide an 
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indication of the risk of TB. Although many studies have examined the association 
between the magnitude of the tuberculin test reaction and the subsequent risk of TB, 
this evidence has not been collectively evaluated (Watkins et al., 2000).Tuberculin is 
a purified protein derivative (PPD) from tubercle bacilli. Following infection with 
M. tuberculosis, a person who is intradermally injected with (PPD) develops 
hypersensitivity to tuberculin (WHO, 1996). Tuberculin PPD is isolated from a 
culture filtrate of tubercle bacilli by protein precipitation. Most of the constituents of 
PPD are small proteins with molecular masses of approximately 10,000 Da, but 
there are also polysaccharides and some lipids present. The relatively small size of 
the protein constituents in PPD is the reason that PPD does not sensitize individuals 
who have not been exposed to mycobacteria (Daniel, 1980).  
1.10.2.1 Immunologic basis for the Tuberculin Reaction 
The reaction to intracutaneously injected tuberculin is the classic example of a 
delayed (cellular) hypersensitivity reaction. T cells sensitized by prior infection are 
recruited to the skin site where they release lymphokines (Tsicopoulos et al., 1992). 
These lymphokines induce induration through local vasodilatation, edema, fibrin 
deposition, and recruitment of other inflammatory cells to the area (Colvin et al., 
1979). Features of the reaction includes delayed course, reaching a peak more than 
24 h after injection of the antigen; indurated character; and occasional vesiculation 
and necrosis. Reactivity of the PPD provides a general measure of a person’s cellular 
immune responsiveness (Daniel, 1980). Typically, the reaction to tuberculin begins 
5 to 6 h after injection, causes maximal induration at 48 to 72 hours, and subsides 
over a period of days. In a few individuals (the elderly and those who are being 
tested for the first time), the reaction may not peak until after 72 hours (Robertson et 
al., 1996). Such delayed reactions do not alter the interpretation of the test. 
Immediate hypersensitivity reactions to tuberculin or constituents of the diluent can 
also occur. These reactions disappear by 24 h, and should not be confused with 
delayed hypersensitivity reactions. However, if the immediate reaction is severe, it 
may be prudent not to retest (American Thoracic Society, 2000). A common 
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problem in those people who are regularly screened for TB infection using the skin 
test (e.g. healthcare workers) is that they start to become immunized to PPD by its 
repeated administrations. This is called 'boosting' and results in a false positive 
reaction to the skin test (American Thoracic Society, 2000).  
The Tuberculin Skin Test (TST) is based on the development of delayed 
hypersensitivity to antigenic components of tuberculin in individuals infected with 
M. tuberculosis. Although reactivity to tuberculin is a continuous phenomenon, TST 
results have traditionally been referred to as positive or negative (Comstock, 1975). 
In view of evidence indicating the variability of tuberculin reactivity under different 
conditions (Comstock, 1975) and among different populations (Edwards et al., 
1968). A number of factors may influence the degree of tuberculin reactivity, and 
must be considered when determining the criterion for a positive reaction. These 
include the prevalence of non-tuberculous mycobacterial (NTM) infection, previous 
bacille Calmette-Gúerin (BCG) vaccination, age, and exposure to active TB, country 
of birth, immune-competence, chest X-ray appearance and socio-economic status 
(American Thoracic Society, 1990).Severe illness, particularly in the elderly, may 
also impair tuberculin reactivity.(Furcolow et al., 1948). Infection with NTM or 
BCG vaccination are important confounding factors in the interpretation of the TST 
(Edwards et al., 1968 and Comstock, 1971) and no reliable method exists to 
distinguish between reactions induced by infection with M. tuberculosis and BCG ( 
Lein and Von, 1997) The distribution of reactions to M. tuberculosis is defined most 
accurately in a population free from other causes of mycobacterial sensitisation. This 
is not the case for most populations. In areas of high NTM prevalence, the specificity 
of the TST declines because an increased proportion of positive tests are due to 
cross-reactions (Edwards et al.,1973). Cross-sensitivity between tuberculin and 
NTM has been associated with medium-sized tuberculin reactions which make it 
difficult to identify M. tuberculosis-infected individuals (Narain et al., 1992)  
 
 
                                        37
1.10.2.2 Interpretation of Skin Test Reactions 
To interpret the tuberculin skin test appropriately, one must understand the 
sensitivity and specificity of the test as well as the positive and negative predictive 
value of the test. The sensitivity of a test is the percentage of people with the 
condition who have a positive test. If false-negative results are uncommon, the 
sensitivity is high. The PPD skin test has a reported false-negative rate of 25% 
during the initial evaluation of persons with active tuberculosis (Holden et al., 1971) 
1.10.2.2.1Value of a negative tuberculin skin test  
             The tuberculin test is negative when the diameter of skin induration is less than 
10 mm in tropical countries. This is regardless whether or not the person has had 
BCG. A negative test does not ascertain that some one does not have tuberculosis as 
a recent infection may exist.   
1.10.2.2.2 Value of a positive tuberculin skin test  
    The criterion for a positive tuberculin test depends on whether a child had 
previous BCG vaccination or not. This is because a reaction to tuberculin is usual 
after a previous BCG vaccination at least for several years.  This reaction is usually a 
weaker reaction (diameter often less than 10 mm) than the reaction to natural 
infection with M. tuberculosis. Therefore, in a child who has no BCG vaccination, a 
tuberculin test is positive when the diameter of skin induration is 10 mm or more. In 
a child who had BCG vaccination, a test is positive when the diameter of induration 
is 15mm or more. A positive tuberculin test is only one piece of evidence in favor of 
diagnosis of tuberculosis. The older the person and greater the diameter of 
induration (above 10-15 mm), the stronger is that one piece of evidence (WHO, 
1996). 
1.10.2.2..3 Conditions which may suppress the tuberculin skin test  
      The reaction would be suppressed due to one or more of the following 
conditions: HIV infection, malnutrition, severe bacterial infections including 
infection with TB itself, viral infections, e. g measles, chicken pox and glandular 
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fever, cancer and immunosuppressive drugs intake, e. g steroids. Factors that may 
cause false-positive and false-negative reactions to the tuberculin skin test are shown 
in Table (3). 
1.10.2 Enzyme Linked Immunosorbent Assay (ELISA) 
      In TB patients, the serological response to mycobacterial antigens has been 
primarily evaluated using standard ELISA with in house methodologies and 
protocols which certainly differ from laboratory to laboratory. Few commercial tests 
based on the detection of specific antigens, such as the 38 kDa protein, have been 
developed and have been in use, primarily in developing countries (Wilkinson et al.,  
1997). There is still a need to improve the sensitivity or specificity of commercial 
serological tests. 
 1.10.3 Quantiferon-TB test 
 QuantiFERON-TB® and Bovigam® are two registered products which measure 
the release of interferon-gamma in whole blood from human subjects and cattle 
infected with M. tuberculosis and M. bovis respectively, in response to stimulation y 
PPD. The IFN-γ secreted by T-cells into the plasma is measured by ELISA to 
indicate the likelihood of TB infection. Different studies demonstrated that the 
QantiFERON-TB test was comparable to the skin test in its ability to detect latent 
TB infection. These studies also showed that the QuantiFERON-TB test was less 
affected by BCG vaccination, discriminated responses due to non-tuberculous 
mycobacteria, and also avoided the variability and subjectivity associated with 
administering and reading the skin test (Pottumarthy et al., 1999). 
1.11 Analysis of cell wall mycolic acids 
1.11.1 Thin-layer chromatography (TLC) 
       TLC uses silica plates (stationary phase) on the surface of which the mycolic 
acids extracted from the mycobacterial strain are separated as a result of their 
different affinity for a solvent (mobile phase), advancing by capillarity. Once the 
plate has been stained, each species displays a particular dot pattern according to its  
                                        39
Table.3 Factors that may cause false-positive ad false-negative reactions to the            
                tuberculin skin test. 
 
 
Type of reaction Possible Cause 
 
False-positive 
Nontuberculous mycobacteria 
 BCG vaccination 
 
 
False-negative 
 Anergy 
 Recent TB infection 
 Very young age (< 6 months old) 
  Live-virus vaccination 
 Overwhelming TB disease 
   (CDC, 2000)   
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mycolic acid content that can be identified by comparison with patterns of reference 
strains with known mycolic acid composition run in parallel (Minnikin et al., 1975)  
1.11.2 Gas-Liquid Chromatography  
In GLC, a gas (mobile phase) is used to carry the sample through a liquid 
(stationary phase) contained in a column. Once the lipids extracted from a 
mycobacterial strain have been injected, the high operating temperature of the 
column (about 300°C) produces the cleavage of the mycolic acids in saturated 
methylesters 22-, 24- and 26-carbon atoms long. Along with such mycolic acid 
fragments, saturated and unsaturated fatty acids (including tuberculostearic acid) and 
alcohols are eluted. (Guerrant et al.,  1981; Lambert et al.,  1986; Larsson et al.,  
1985) 
1.11.3 Mass Spectrometry  
      The detection of the glycolipid, lipoarabinomannan, which composes up to   
15% of the dry weight of the cell, has also been demonstrated for diagnostic 
purposes but again is not unique to M. tuberculosis (Hamasur et al., 2001). Rally, 
determination of the specific cell protein composition has been popular and shown to 
be useful for some discrimination of various species of microbes using mass 
spectrometry (Watanabe et al., 2001 ; Laval et al., 2001). Mass spectrometry have 
been used to obtain profiles of mycolic acids, which make up 40 to 60% of the dry 
weight of mycobacteria (Barry et al., 2001). 
1.11.4 High Performance Liquid Chromatography (HPLC) 
        High Performance Liquid Chromatography is based on the observation that 
each Mycobacterium species synthesizes a unique set of mycolic acids, b-hydroxy- 
fatty acids that are components of the cell wall (Butler and Kilburn, 1988). In 1985 
(CDC) proposed the use of HPLC as an aid in mycobacterial classification (Butler, 
1985).  In 1990, it was offered as a standard test for identification of Mycobacterium 
species (Good, 1990). 
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1.12 Phage-based assays 
     The phage-based assay relies on the ability of M. tuberculosis to support the 
growth of an infecting mycobacteriophage. The number of endogenous phages, 
representing the original number of viable bacilli, is then determined in a lawn of a 
rapidly growing mycobacterium such as M. smegmatis (McNerney, 2001). Several 
studies have been performed to assess the FASTPlaque TB assay, a commercial test 
based on this technology, for the early detection of M. tuberculosis (Albert et al., 
2002). In a comparative study with auramine smear microscopy and culture in 
Löwenstein-Jensen medium in 1,692 sputum specimens, it was found that the 
FASTPlaque TB test detected TB in 75 % of culture-confirmed cases and in 70 % of 
cases with aclinical diagnosis of TB with a specificity of 98.7 % and 99.0 %, 
respectively (Muzaffar, 2002). However, FASTPlaque TB failed to detect about 13 
% of the smear-positive specimens and 8 % to 19 % of the smear-negative samples 
gave a false-positive result (Takiff, and Heifets, 2002).An interesting study that 
compared the original in-house method with the FASTPlaque TB found that neither 
method was able to outperform direct microscopy in sputum samples while 
contamination rates of 40 % were obtained with the FASTPlaque TB test (Mbulo, 
2004). Recent modifications to this commercial system include incorporation of an 
antibiotic mixture to decrease the high rate of contamination. Some other phage-
based technologies using reporter mycobacteriophages have also been proposed for 
the rapid detection and identification of M. tuberculosis; however, they have not 
been thoroughly evaluated in clinical settings of highly endemic countries (Carriere 
et al., 1997; Banaie et al., 2001). 
1.13 Control and prevention of tuberculosis 
Tuberculosis prevention and control takes two parallel approaches. In the first, 
people with TB and their contacts are identified and then treated. Identification of 
infections often involves testing high-risk groups for TB. In the second approach, 
children are vaccinated to protect them from TB. Unfortunately, no vaccine is 
available that provides reliable protection for adults. However, in tropical areas 
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where the incidence of atypical mycobacteria is high, exposure to nontuberculous 
mycobacteria gives some protection against Tuberculosis (Fine et al., 2001). 
1.13.1 Tuberculosis Vaccine  
Albert Calmette and Camille Guérin of the Pasteur Institute, attenuated a 
mycobacterium related to M. tuberculosis (Mycobacterium bovis bacillus Calmette-
Guérin (BCG) by growing it in bile salt culture medium for 13 years, through 
monitoring its decrease in virulence in animals (Calmette and Plotz, 1929). The 
current tuberculosis vaccine, bacillus Calmette-Guerin (BCG), is a live vaccine that 
protects against severe childhood forms of disease, including milliary and 
extrapulmonary TB and the often fatal TB meningitis. It also confers protection 
against leprosy. The World Health Organization (WHO) recommends BCG 
vaccination in areas of high TB prevalence and incidence. BCG vaccination is 
currently compulsory in 64 countries and administered in 167 countries (WHO, 
1995). As BCG came into general use, a number of different substrains were 
generated in a number of production laboratories. Some of these substrains, derived 
from the original strain by additional culture passages, lost residual invasiveness and 
were devoid of efficacy. Therefore, any strain used for vaccine production should be 
documented and approved by WHO. There is considerable evidence that 
heterogeneity exists among the different isolates of M. tuberculosis (Rado and Bates, 
1980). Data concerning the protective efficacy of BCG in adults range from 0% in 
South India to 80% in the UK (Fine, 1995). One possible reason for the failure of 
BCG vaccine in the South Indian trial (Tripathy, 1987) is that there was a high 
proportion of disease caused by antigenic variants. (Collins and DeLisle, 1987). 
1.13.2 Chemotherapy of tuberculosis 
 1.13.2.1 History of chemotherapy 
Prior to the introduction of streptomycin in 1940, there was no effective treatment 
for tuberculosis. The development of p-aminosalicylic acid and isoniazid in 1952 has 
enhaced the probability of achieving curative therapy. The introduction of rifampicin 
in 1971 further improved effectiveness of chemotherapeutic regimens. In 1980, the 
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success of 6 months regimens allowed clinicians to shorten the duration of treatment 
in some patients (Harding and Bailey, 1994). However, there are still problems in 
treating tuerculosis including poor patient compliance, multiple drug resistance and 
altered host immune impairment, typically include one or more of the following: 
malnourishment, acquired immune deficiency syndrome (AIDS), haematologic or 
reticuloendothelial malignancy and chronic renal failure (Harding and Bailey,  
1994).  
1.13.2.2Treatment 
The fundamental goal of all tuberculosis control programs should be early 
diagnosis and prompt initiation of an optimal and, if resources allow, supervised 
drug regimen It has recently been argued that the goal of programs should be 
directly observed therapy (Goble et al., 1993 and Iseman et al., 1993). Although 
others have argued for a more selective approach to supervised treatment (Annas, 
1993).Treatment for tuberculosis uses antibiotics to kill the bacteria. The two 
antibiotics most commonly used are rifampicin and isoniazid. However, these 
treatments are more difficult than the short courses of antibiotics used to cure most 
bacterial infections as long periods of treatment (around 6 to 12 months) are needed 
to entirely eliminate mycobacteria from the body. (CDC, 2000). Latent TB treatment 
usually uses a single antibiotic, while active TB disease is best treated with 
combinations of several antibiotics, to reduce the risk of the bacteria developing 
antibiotic resistance (Brien, 1995).People with these latent infections are treated to 
prevent them from progressing to active TB disease later in life. However, treatment 
using Rifampin and Pyrazinamide is not risk-free (CDC, 2000).  
1.14 Multi-drug resistance tuberculosis (MDR-TB)  
      MDR-TB strains are generally considered to be those resistant to at least INH 
and RIF (Goble et al., 1993). These strains have been described worldwide, and their 
existence poses a serious threat to TB control programs in many countries (Frieden 
et al., 1995). The frequency of secondary resistance is more common than primary 
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one. In principle, treatment of patients with MDR-TB is substantially more difficult 
than individuals infected with drug-sensitive strains. MDR-TB strains could arise as 
a consequence of sequential accumulation of mutations conferring resistance to a 
single therapeutic agent, or only sinlge-step process such as acquisition of MDR 
element, or mutation that alters, for example, cell wall structure. All available 
evidence indicates that the former process is critical to the emergence of these 
organisms (Ramaswamy and Musser, 1998). 
          Drug resistant tuberculosis is transmitted in the same way as regular TB. Primary 
resistance occurs in persons who are infected with a resistant strain of TB. A patient 
with fully-susceptible TB develops secondary resistance (acquired resistance) during 
TB therapy because of inadequate treatment, not taking the prescribed regimen 
appropriately, or using low quality medication. Drug-resistant TB is a public health 
issue in many developing countries, as treatment is longer and requires more 
expensive drugs (O'Brien, 1995) 
1.14.1 Extensively drug resistant TB (XDR-TB) 
        Defined as MDR-TB with additional resistance to any fluoroquinolone, and to 
at least one of the three following injectable drugs used in anti-TB treatment: 
capreomycin, kana- mycin and amikacin (Raviglione, 2006). 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Study population  
 In this study 279 patients, who visited the out patient clinic at Alshaab 
Teaching Hospital, Khartoum state, during the period from February 2007 to 
February 2008, were included. They were referred as patients having tuberculosis 
infection according to the symptoms of dry cough, fever, and loss of weight 
according to WHO (I996). All patients were examined for reactivity to tuberculin 
test and for the presence of acid-fast bacilli. 
2.2 Data collection 
Clinical information in parallel with the laboratory evaluation of the clinical 
specimens was obtained. The clinical history and demographic data of all patients 
were collected using structured questionnaire with informed consents. Participants 
were divided into groups according to age, sex and occupation. 
2.3 Tuberculin Skin Tests 
  All patients were tested for tuberculin skin reactivity, using the Mantoux test 
(intracutaneous tuberculin units manufactured by Span Diagnostic Ltd, G.I.D.C 
India). One-tenth milliliter of a commercially available purified protein derivative 
tuberculin was injected intracutaneously in the skin of forearm of the patients using 
insulin needles. The delayed skin reaction was read after 48–72 hours. The diameter 
of the induration was measured in mm. Positive tuberculin test was considered and if 
the wheal reaction was 10 mm or over (James, 2004)  
2.4 Sputum collection 
                   Sputum samples were collected according to WHO criteria (1996) the deep 
cough material of the morning was obtained from patients in sterile, plastic, screw-
caped containers. Samples were recorded by identification number and processed in 
the same day of collection  
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2.5 Sputum smears preparation  
    Thin smears from sputa were prepared in new, clean, unscratched slide and 
labeled at one end with the relevant patient number. An adequate portion of the 
specimen was transferred on the slide and a smear was made over an area of 
approximately 2.0 by 1.0 cm using an applicator stick in order to make smear thin 
enough to be able to read through it. Smears were allowed to dry by air for 15 
minutes and fixed by passing the slides through a flame three or four times with the 
smear uppermost. Applicator stick was discarded in the disinfectant or a biohazard 
receptacle, and a new one was used for each specimen.  
2.6 Ziehl-Neelsen stain 
Reagents 
Fuchsin  
Basic fuchsin                                                                  3%  
95%  ethanol                                                                   100ml  
Basic fuchsin was dissolved  in ethanol                          Solution 1 
Phenol 
Phenol crystals                                                                5g 
 Distilled water                                                                100ml 
Phenol crystals were dissolved in distilled water.             Solution 2 
 
Working solution 
Combine 10ml of solution 1 with 90ml of solution 2 and stored in an amber bottle.  
Decolourising agent: 3% acid-alcohol 
Concentrated hydrochloric acid                               3ml 
Ethanol   95%                                                          97ml                                                            
Concentrated Hydrochloric acid was carefully added to 95% ethanol.  
Counterstain Methylene blue 
Methylene blue                                                         0.3g  
Distilled wate                                                          100ml 
        Methylene blue was dissolve in distilled water and store in an amber bottle  
     2.6.1 Staining procedure  
          Slides were placed on a staining rack in batches. Slides were flooded with 
strong carbolfuchsin; slideS were passed over the flame for 3 –5minutes until it was 
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steaming. Then slides were washed with tap water and decolorized with 3% acid 
alcohol for 2-3 minutes and washed again with tap water. Finally, methylene blue 
was added for 30 seconds as counter stain, slides were allowed to dry by air in 
inclined position without blotting. The slides were then examined under oil 
immersion lens (x100) for demonstration presence of AFB. Sputum samples 
containing AFB were cultured in Löwenstein-Jensen medium.  
2.7.1 Lowenstein Jensen medium for isolation  of M.tuberculosis  
Mineral salt solution  
Components                                                                            (g/l) 
Potassium dihydrogen sulphate                                                2.40g 
(KH2SO4) Magnesium sulphate(Hydraus)                                   0.2g 
(MgSO47H2O) 
Magnesium citrate                                                 0.60g 
Glycerol                                                                               12.ml 
Ingredients above were dissolved in 600 ml distilled water and autoclaved at 
110°C for 15 minutes 
Malachite green solution    
Malachite green                                 0.2g 
Distilled water                                   10ml 
Malachite green was mixed with distilled water and placed in water bath 56-60 to 
dissolve and autoclaved at 115°C for 10 minute 
Egg mixture  
(whole-egg)                              20 hen’s egg 
Ethanol                                      70%  
Preparation: This medium was prepared according to Barrow and Feltham 
(1993), twenty hens egg were immersed 70% ethanol and leaved for 15 minute then 
removed to a clean tray to dry then were breaked in sterile beaker and white and 
yolks were mixing by homogenized.Then the 600 ml Mineral salt solution were 
mixed with 1000 ml sterile whole-egg homogenate containing 20 ml 1% to give a 
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homogenous mixture. Then 5 ml of the mixture were dispensed into sterile glass 
universal bottles, and inspissated in a slant position at 85 °C for 45 minute. 
2.7.2 Culture method 
2.7.2 1 Decontamination and concentration of sputum  
Reagents: 
IN HCl                                                                                      8.3 ml  
D. W.                                                                                       91.7 ml  
IN NaOH                                                                                     4g/100ml  
Phenol red                                                                                              1g 
Distilled water                                                                                   50 ml  
Procedure: The sputum was aseptically transferred into sterile 50 ml conical tube, 
equal volume of IN NaOH was added, then vortexed and kept at room temperature 
for 20 minutes. The sputum was neutralized with IN HCl, which was added drop by 
drop until the colour changed (Petroff, 1915).  
2.7.2 2 Inoculation of Lowenstein-Jensen (L. J.) medium 
    Two tubes of L. J. medium were inoculated with 4 drop Pasteur pipette of the 
neutralized sputum sample. One of the two tubes contained glycerol while the other 
one contained pyruvic acid to isolate M. tuberculosis and M. bovis respectively   
(Mackie ad McCartney, 1996 ). Inoculated tubes were incubated aerobically at 37°C 
for up to 8 weeks before being discarded. Growth was monitored daily during the 
first week to observe the presence of rapidly growring mycobacteria and Nocardiae 
if present, which can show growth within 7 days, and then the growth, was observed 
weekly up to the 8th week. Characteristics of different colony types found were 
observed and recorded and Smears from each culture were made for microscopy. 
Enough growth of M. tuberuclosis complex members mostly appeared after 6 weeks.  
2.8 Biochemical testing 
 Selected biochemical tests were performed for the identification of the 
isolates. All tests were done according to Mackie and McCartney (1996).  
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Preparation of mycobacterium fresh suspension One milliliter of sterile distilled 
water and 5-7 glass beads (3 mm in diameter) were put in a sterile screw-capped 
bottle. A loopful of solid growth was transferred to the bottle and the mixture was 
vortexed for 10 seconds. With a sterile Pasteur pipette 2 drops of the suspension 
were added to a slope of LJ medium.  
2.8.1 Catalase test 
Reagents 
Solution 1 
     Na2HPO4                                                                 9.47g 
     Distilled water                                                          1000ml  
    Solution 2 
     KH2PO4                                                                      9.07g 
     Distilled water                                                       1000ml  
     Tween 80, 10% 
     Tween 80                                                                       10ml 
     Distilled water                                                              90ml  
Solution 1&2 were mixed to provide an 0.067 M phosphate buffer.  
A solution of equal parts of 10% Tween 80 and 30% hydrogen peroxide were mixed 
immediately before use. 
2.8.1.1Test Procedure 
It is a semi quantitative method and performed as described by Betty, Daniel 
and Alice (1998).  Aseptically, 0.5 ml of 0.06 M phosphate buffer was added in a 
test tube, and then several loopfulls of solid culture from 14 days-old culture were 
transferred into buffer solution. Then the tube was incubated in water bath at 68°C 
for 20 minutes. After 20 minutes the tubes were cooled at room temperature. Then 
0.5 ml of freshly prepared tween-peroxide mixture in a test tube was added and the 
cap was replaced and left loosely. A column of foam was formed if the catalase test 
is positive, the height of the column was measured; the results were interpreted 
according to (IUATLD, 1998) as follows:        
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Less than 31 mm of foam =Low or no catalase activity 
Between 31 and 45 mm of foam =moderate activity  
More than 45 mm of foam = High  catalase  activity 
2.8.2 Nitrate reduction test 
Reagents 
Solution 1 
1-Phosphate buffer  
KH2PO4                                                                                3.02g 
Distilled water                                                                         1000ml  
Solution 2   
Na2HPO4                                                                                 3.16g 
Distilled water                                                                     1000ml  
2-sodium nitrate Solution 
NaNO3                                                                                  0.85g 
Distilled water                                                                      1000ml 
3-Hydrochloric acid solution: 
Concentrated HCL                                                                          10ml 
Distilled water                                                                          10ml 
4-Sulfanilamide solution, 0.2% 
Sulfanilamide                                                                            0.2g 
Distilled water                                                                        100ml 
5-N-naphthylethylene- diamine solution, 0.1%: 
N-naphthylethylene- diamine solution                                   0.1g 
Distilled water                                                                              100ml 
2.8.2 1Test Procedure  
Nitrate reduction test was done according to Betty et al. (1998). In a screw–
capped tube 0.2 ml of sterile saline was placed, and then 2 loopful of a 4-weeks old 
solid culture were emulsified in the saline. Then 2 ml of NaNO3 were added, and the 
tube was well shaken and incubated upright at 37°C in a waterbath for 3 hours. One 
drop of diluted HCl was added and the tube was shaken  well, then 2 drops of 0.2% 
of sulfanilamide and 2 drops of 1% naphthylethylene-diamine were added and the 
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mixture was examined immediately positive result was indicated by production a 
pink to red color,. If no color, devolthe result was taken as negative.   
2.8.3 Sensitivity to para-nitrobenzoic Acid (PNB)  
L .J medium slope with PNB 
PNB                                                                                              0.2g 
Distilled water                                                                          15ml 
NaOH (1 mole/1)                                                                     2ml
 2.8.3.1Test Procedure 
The test was done according to Mackie and McCartney (1996). A loopful of 
fresh solid culture was inoculated onto a slope of LJ medium containing 500 mg/l 
PNB and then incubated at 37°C for 4 weeks. The presence of growth indicated that 
the organism was resistant to PNB 
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CHAPTER THREE 
RESULTS 
 
3.1 Reactivity to tuberculin  
  Positive tuberculin skin test was scored as delayed-hypersensitivity tissue 
reaction, manifested as an area of oedema or induration with a wider erythromatous 
zone measuring more than 10 mm in diameter. Negative tuberculin skin test gave an 
induration less than 10 mm in diameter. From 279 subjects studied, 173 (62%) were 
found positive for TST and gave induration ranging from 10 to 25 mm in diameter 
as eleprated in fig (3.1) and (Table 3.1). Those negative for TST were 106 (38%) 
subjects gave no reaction presented or an induration ranging from 3 to 8.mm in 
diameter as depicted fig (3.1)    
3.2 Effect of BCG vaccination on reactivity to tuberculin test   
   Among the total number of Individuals 279 only 50 (18%) were BCG 
vaccinated. and majority 229(82%) were BCG-unvaccinated. All BCG vaccinated 
individuals were TST positive. However, 123 BCG unvaccinated Individuals were 
found TST positive. No AFB was demonstrated in sputum of BCG vaccinated 
individuals but AFB was demonstrated in 27 sputum samples in BCG-unvaccinated 
Individuals. Fig 3.3 and Table 3.2 shows tuberculin reactivity and the demonstration 
of AFB in BCG vaccinated and non-vaccinated Individuals. 
3.3 Effect of age on reactivity to tuberculin test            
      Tuberculin reactivity in the different age groups is shown in Table (3.1) and Fig 
(2). Of Individuals with age less than 15 year (G1) only 6 (1.9%) were vaccinated, 
while 20(6.33%) were found positive for tuberculin skin test reaction and 
33(10.44%) were negative. In Individuals with age  (16-30) year(G2), 85 (26.90%) 
were positive for tuberculin skin test and 35 (11.08%) were negative for tuberculin 
skin test .In the third age group  (31-45) year,43(13.61%) were TST positive and 
13(4.11%)were TST negative, whereas in the fourth group of age more than 45 year 
25(7.91%) people were positive for tuberculin skin and 25(7.91%) were found 
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negative for tuberculin skin test Fig 3. 2 shows the effect of age on reactivity to 
tuberculin test        
3.4 Effect of sex on reactivity to tuberculin test            
       From 279 subjects who attended the tuberculin reading, 167 were males and 112 
were females. Tuberculin positive males were 37.63%. In contrast tuberculin 
positive females were (24.37%). BCG vaccinations among males were (13.8 %) and 
those among females were (24.11). Positive sputum smear of males were (12%) and 
those of females were (5.7%). Fig (3.4) shows tuberculin reactivity and BCG 
vaccinations and the demonstration of AFB according to sex.  
 3.5 Effect of occupation on reactivity to tuberculin test  
     Positive tuberculin reactivity among housewives (n=65) was (45)and students     
(n=120) was (61) On the other hand positive tuberculin skin test (TST) among labours 
(n=30) was (18) and among unemployed people (n=28) was (18) and employee 
(n=36) was (31) and the demonstration of AFB in housewives was (5) and students (6) 
and labours (7) and among unemployed (0) and employee (9) fig (3.4) table (3.3)    
show reactivity to tuberculin according to occupation    
3.6 Isolation and Identification of M. tuberculosis 
3.6.1 Demonstration of AFB by staining with Ziehl-Neelsen stain 
 Since tubercle bacilli do not occur as commensals in healthy persons, their 
demonstration in sputum is a proof of existence of tuberculosis disease. The finding 
of AFB in sputum is a good presumptive evidence of the presence of pulmonary 
tuberculosis. From 279 sputum collected AFB were demonstration in 27 samples 
such provisional diagnosis based on microscopic finding is of great value because 
find identification of M. tuberculosis by culture or animal inoculation takes several 
week. All sputum sample positive for AFB were collected from Non-BCG-
vaccinated subjects. This accounts for (9.7%) of the total sample collected and 
10.2% of non BCG-vaccinated patients (11.9%) male and (6.3%) were female. 
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3.6.2 Isolation of M. tuberculosis from AFB positive sputum and culture                    
         characterization   
 Positive sputum Smears, were cultured on Lowenstein Jensen medium, the 
isolates showed visible growth after 2 weeks. The growth rate of 27 isolates ranged 
between 2 to 5 weeks and they were identified as slow growers and considered to 
belong to M. tuberculosis complex species.  
All isolate were showed M. tuberculosis complex like colonies, considered 
slowly growing   Mycobateria, and the M. tuberculosis complex like colonies were 
confirmed by some biochemical tests. Cultural characteristic of all isolates of M. 
tuberculosis complex on Lowenstein Jensen medium at 37 ºC were almost the same 
and all colonies were found dry, rough and cream (buff) colored (Fig.6).  
Each isolate was kept in Lowenstein Jensen medium and given a code and 
number as shown in table (3). Although biochemical reaction are not ordinarily used 
in the identification or classification of tubercle bacilli few biochemical test were 
performed as shown in table (3). All strains were resistant to para-nitrobenzoic acid 
(PNB), catalase positive and reduce nitrate. 
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Figure: 3.1 Tuberculin test reactivity in various groups 
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Table: 3.1Tuberculin reactivity and the demonstration of AFB in BCG-vaccinated 
and non-BCG vaccination Individual according to Age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
G=Group; Pos=Positive; Neg=Negative; Vacc=Vaccinated; Unvacc=Unvaccinated ; 
  Number= number of patient 
 
 
 
     Fig.3.2: Tuberculin reactivity in various age groups 
 
 
 
 
Age groups 
 
Number 
 
Vacc Unvac AFB Pos (%) TST Pos (%) 
G1 (≤15) 53 06 47 00 (00.00%) 20 (37.7%) 
G2 (16-30) 120 23 97 20 (16.70%) 85 (70.8%) 
G3 (31-45) 56 09 50 05 (8.93%) 43 (76.8%) 
G4 (>45) 50 12 35 02 (4.00%) 25 (50%) 
Total 279 50 229 27 (9.7%) 173 (62%) 
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Table: 3.2 Tuberculin reactivity and the demonstration of AFB in vaccinated  
                    and non-BCG vaccination Individual 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3 BCG vaccination and the demonstration of AFB in BCG vaccinated        
           and non-BCG vaccinated Individuals 
 
 
 
 
BCG Vaccine 
 
 Numbers 
 
Percentage (%)
 
Infected
 
Percentage (%) 
 
Vaccinated  
 
50 
 
17.9% 
 
00 
 
00% 
 
Non-
vaccinated  
 
229 
 
82.1% 
 
27 
 
9.7% 
Total 279 100% 27 9.7% 
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Table: 3.3 Tuberculin reactivity and the demonstration of AFB and  
           recovery of M .tuberculosis in culture according to occupation                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.4 Tuberculin reactivity and the demonstration of AFB according to 
occupation 
 
 
 
Occupation Numbers AFB  positive
Percentage 
(%) 
TST 
 positive
Percentage 
 (%) 
Students 120 6 2.2%% 61 21.9% 
Housewive 65 5 1.8% 45 16.13% 
Employee 36 9 3.22% 31 11.11% 
Labours 30 7 2.5% 18 6.5% 
Unemployed 28 0 0000% 18 6.5% 
Total 279 27 9.7% 173 62% 
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Table: 3.4 Demonstration of AFB and the tuberculin reactivity and BCG                                 
                 vaccinations according to sex 
TST= Tuberculin Skin Test 
 
 
 
 
 
 
 
Fig.3.5 Tuberculin reactivity and BCG vaccinations and the demonstration         
            of AFB according to sex   
 
 
 
Sex 
 No 
AFB 
Positive 
TST 
Positive 
TST 
Negative 
BCG 
Vaccinated 
BCG non 
vaccinated 
Male 
 
167 
 
20 
(11.98%) 
 
105 
(62.87%) 
 
62 
(37.12%) 
 
23 
(13.77%) 
 
144 
(86.23%) 
 
 
Female 
 
 
112 
7 
(6.3%) 
 
68 
(60.72%) 
 
44 
(39.3%) 
 
27 
(24.10%) 
 
85 
(75.9%) 
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         Fig.3.6 Growth of Mycobacterium tuberculosis on Lowenstein 
            Jensen medium showing typical cream (buff)-colored rough 
              colonies against the green egg-based medium. 
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CHAPTER FOUR 
DISCUSSION 
 Mycobacterium characteristically, produces granulomatous lesions, which in 
the case of tuberculosis and brokendown by caseation (William et al., 2004) 
The most common site of infection is the lung (pulmonary tuberculosis) but lymph 
nodes, bones, Joints, brain, and meninges and other internal organs may be affected 
Tuberculosis (TB) is a major public health threat in many countries including the 
Sudan and one of the most common causes of hospital deaths. The annual risk of 
infection is 1.8%, the most frequent reason for hospital admission, constituting 
11.6% of all cases admitted in hospitals, and the most frequent cause of hospital 
deaths, constituting 16% of all patients who died in hospitals (Elsoney, 2000).  
       The prevalence of tuberculosis infection in contra-distinction to clinical disease 
may be estimated by use of tuberculin test and when found positive, this indicate 
that the individual has at sometime been infected by tuberculosis bacillus without 
necessary showing overt sign of the disease (James,2004). In this study the 
prevalence of mycobacterium infection among the out patient at Alshaab Teaching 
Hospital was 62. %. Although the tuberculin skin test is the only available method 
for detecting M. tuberculosis infection, the test is neither 100% sensitive nor 100% 
specific (Huebner et al., 1993). In case of non-tuberculous mycobacteria or 
vaccination with BCG, the specificity of the tuberculin test will be low. The positive 
predictive value of the tuberculin test is also variable. As the prevalence of TB 
infection in the population decreases, the positive predictive value of the tuberculin 
test also decreases. Appropriate interpretation of skin test results requires knowledge 
of the antigen used (tuberculin) and the immunological basis for the reaction to it 
and the technique of administering and reading the test (Jerant et al., 2000). 
    In this study standardized tuberculin in the form of purified protein derivative of 
Mycobacterium tuberculosis was injected intracutaneously (intracutaneous 
tuberculin units manufactured by Span Diagnostic Ltd G.I.D.C India).A positive test 
appeared as a delayed- hypersensitivity reaction manifested as an area of oedema or 
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induration with a wider erythromatosus zone. The diameter of induration was 
measured after 72 hours and the reading was scored in mm. The Sudan, like other 
warm climate country, non specific tuberculin reaction presumably related to 
infection with other than mammalian tubercle bacilli (saprophytes) are common. In 
this study 62.01% of patients that showed a reaction of ≥10mm were considered 
positive for the test and were more likely had previous infection or BCG 
vaccination. The indurations ranged in diameter from 10 to 15mm. Rieder (1995) 
reported that palpable indurations of ≥10 mm at the injection site were taken as 
evidence of tuberculous infection.  
      Because PPD comprises a complex mixture of proteins, the interpretation of a 
positive Mantoux test still faces serious specificity concerns. Several proteins in 
PPD are also found in most Mycobacterium species, including several environmental 
organisms (Daniel et al., 1978; Hopewell and Bloom, 1998).Therefore exposure of 
humans to these Mycobacterium species can ultimately render them reactive to PPD. 
Several previous attempts have been made to identify the components in PPD 
responsible for the elicitation of DTH in Mycobacterium-sensitized persons. 
Although several Mycobacterium molecules, including MTP 64, MPT 59, the 71-
kDa heatshock protein, and a-crystallin, elicited DTH in immunized or sensitized 
guinea pigs, none have elicited DTH in humans like that elicited by PPD (Oettinger, 
1995 and Nakamura, 1998).However the risk of misinterpretation of tuberculin test 
positive reaction in these patients may be minimal by using dual tuberculin testing as 
we described that before (Omer et al., 1980)  
        In this study the  prevalence of mycobacterium infection at the out patient clinic 
at Alshaab Teaching Hospital was 62. % and , similar high prevalence of positive 
tuberculin tests were reported by Bener (1990), and Al-Kassemi (1993).The recent 
interpretation of the tuberculin test is that patient positive of TST harbour viable 
mycobacteria sequestered some where in their body. These viable cells were 
probably from natural infection or BCG vaccination.  
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In present study the distribution of tuberculin reactivity was associated with age and 
domination of the age group of 16 to 30 years. This finding is in line with Bener 
(1990), who reported that tuberculin reactivity was 52% for those ages between 45–
64 years old. Furthermore Shiddo et al. (1995) in Somalia reported a continuous 
increase in the prevalence of tuberculin- positive reactions with increasing age, 
indicating lifelong cell-mediated immunity in Tuberculosis. In contrast regarding the 
correlation between the age of patients and infection rate, it was found that young 
patients between 16 and 45 years were the most affected group, a similar finding 
was obtained by EL Eragi (2004), who found that patients with ages between 11-40 
years were at the most risk. Also, Murray, Styblo and Rouillon (1990) reported that 
almost 80% of TB patients were living in developing countries with an age less than 
50 years, and in contrast, in the developed countries most cases were over 50 years. 
This can be attributed to the fact that this range of age represents the productive and 
dynamic age group, thus, in addition to the poverty such as malnutrition and poor 
living conditions are the predisposing factors.  
The current study showed that tuberculin reactivity among different 
occupations, housewives, students, labours, employee, and unemployed was 
16.13%, 21.86%, 6.45%, 11.11%, and 6.45%   respectively. The prevalence of AFB 
in housewives, students, labours, employee, and unemployed was 1.58%, 1.9%, 
2.22%, 2.85%, and 0.00% respectively. This finding agrees with the statement that 
economic status play a major role in TB morbidity, in addition, there are many other 
factors such as overcrowding of poor and ill-nourished people, racial differences and 
in availability of health care (Lowel, 1976). 
Because the majority of the study subjects did not received BCG vaccine (82.1%) 
the high prevalence of positivity of TST indicate these patients were infected with 
M. tuberculosis or other Mycobacteria. It has been proposed by Castelo et al.,2004 
that TST indicates infection with M. tuberculosis when the indurations area is 
greater than 10 mm in adults not vaccinated with BCG or those vaccinated more 
than two years prior to the examination; or the indurations is greater than 15 mm in 
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adults vaccinated with BCG less than two years prior to the examination. Other 
important uses of tuberculin test includes: contact tracing of infections cases of 
tuberculosis in families and close relative as well as for post-vaccination check on 
the efficacy of BCG vaccination. Immunity to tuberculosis is cell mediated 
immunity and tuberculin test is manifested as delayed type hypersensitivity reaction 
which is for measurement of cell-mediated immunity. Only live vaccine induces 
protective immune response and BCG may give good protection of order of 80% 
against clinical infection (Fine, 1995) 
    In this study no AFB was demonstrated in sputum of BCG vaccinated individuals 
50 (15.82%). This finding might strengthen the value of BCG vaccination in 
protection against tuberculosis despite to previous report of BCG failure in the South 
India, (Tripathy, 1987 and Fine, 1995). Previously Palmer et al (1953) reported poor 
protection rate of BCG of 14-31%. However various factors have been blamed these 
discrepant finding such as malnutrition, vaccination with unprotective potencies of 
BCG vaccine, the purity of the tuberculin used to distinguish infected from resistant 
individual and  in particular, the high level of non specific hypersensitivity in warm 
climate like Sudan(Omer et al., 1980). Since tubercle bacilli do not occurs as 
commensals in healthy persons their demonstration in sputum is proof of existence 
of pulmonary tuberculosis. Commensal and saprophyte mycobacteria are rarely 
found in the respiratory tract, hence the finding of AFB in the sputum is good 
presumptive evidence of the presence of pulmonary tuberculosis. Microscopic 
sensitivity and specificity worldwide recorded ranging from 84% (WHO, 1996) to 
up to 88 %.( Shinnick, 1994). Many factors may influence the accuracy of this 
method notably the degree of bacilli shedding in sputum (sensitivity and specificity) 
and the technical capabilities of the laboratory. Out of 279 patients included in this 
study using ZN, 252 were negative for AFB samples and 27 were positive for AFB. 
In the Sudan laboratory the detection of acid fast bacilli (AFB) in sputum or biopsy 
samples is the main method used for diagnosis of TB and tuberculin testing is the 
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only method used, sometimes, for surveys and detection of new non-clinical cases 
(WHO, 1996 and WHO, 2002) 
    In the present study sputum of 27 patients AFB were demonstrated by direct   
microscopy. This is agreement with (Hobby et a1., 1973). Such provisional   
diagnosis based on microscopic finding is of great value because the final 
identification of mycobacteria tuberculosis by culture and animal inoculation takes 
several weeks. Moreover tubercle bacilli are most numerous in lesion showing rapid 
caseation as in adult pulmonary tuberculosis, open pulmonary tuberculosis. However 
in chronic or closed lesion few bacillus were observed and they may not be 
detectable microscopically but could be demonstrated by culture or animal 
inoculation. To demonstrate tubercular bacilli by direct microscopy a strongly acting 
dye of 10% strong carbol fuchsin was used with heating to facilitate impregnation 
followed by decolourization with 3%acid alcohol and 1% methyline blue was used 
as counter stain. This is Ziehl-Neelsen stain modification of a method originally 
described by Ehrlich .Tubercle bacilli appeared red slender and straighter slightly 
curved on blue background. The critical stage of staining is the method of drying the 
stained smear slides were air dried in inclined positions without blotting.Blotting 
remove the smear all together. However direct microscopy negative result  do not 
exclude tubercle bacilli, since at least 105 tubercle bacilli must be present in one ml 
sputum for reasonably ready demonstration of a positive  microscopic result as 
reported previously (Hobby et a1.,1973 and  Samb et al.,1999 in Senigal),Our 
sputum sample from all patient were carefully collected early in the morning to 
ensure that our specimens did not consist of purulent secretion coughed up from the 
bronchi and was not merely saliva spat from the mouth. Furthermore, direct 
microscopy examination is insensitive screening method for demonstrating of the 
presence of AFB which might or might not be M. tuberculosis. Because of this 
limitation and because of culture of tubercle bacilli are required for accurate 
identification and for drug sensitivity testing all sputum positive samples were 
culturing on an egg containing medium. First all sputum samples were 
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decontaminated with 4% NaOH was found optimal to inhibit pharyngeal 
commensals bacteria which grow more rapidly and suppress the grows of 
Mycobacteria. The egg containing medium was LJ media prepared in screw cap 
container in order to preserve moisture during the prolonged incubation period of up 
to 6-8 weeks was found satisfactory. In addition LJ media contains malachite 
green dye that inhabited growth of contaminant. All cultures were carefully and 
properly conducted to recover M. tuberculosis. In this study we found the prevalence 
of tuberculosis among the population studied was 9.7% among non-BCG vaccinated 
patients and no AFB was detected in BCG vaccinated patients. In this study the high 
prevalence of the disease was because all samples were collected from referred 
patients highly suspected of tuberculosis. In contrast Hamid et al. (2001) reported 
that out of 400 sputum samples taken from patients suffering from pulmonary 
infection, 8 (2%) samples identified as Nocardia. Nonetheless culture method was 
reported as much more sensitive than microscopy (Colebunders and Bastian, 2000). 
Also Tarig et al 2004 reported that around 6-10% of the pulmonary infections in 
Khartoum Hospital, were due to AFB other than tubercle bacilli including M. 
species, Nocardia spp. and fungi. This finding showed that culture method might be 
more specific than the smear method which can not differentiate between M. 
tuberculosis, AFB other than tubercle bacilli and Nocardia. When Mycobacterium 
tuberculli present in numbers as few as 10 per ml of sputum usually missed by direct 
microscopic examination. As reported by Hobby et al., (1973). In this study it was 
found that the number of pulmonary TB-infected males was higher than that of the 
females, 62.9 % and 60.8% respectively. A similar result was reported by El Eragi 
(2004), who found that 66.7% of cases were males and 33.3% were females. This 
finding is also in accordance with that of Bellamy et al., (2002), who said that an X 
chromosome susceptibility gene contributes to the high susceptibility of males to TB 
than females as observed in many different populations. Moreover, according to the 
job type, males are more exposed to sources of infection than females. 
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The 27th isolate   were given code and a number. Human strain isolate grow 
more luxuriantly in culture (eugenic) than do bovine strain the addition of low 
percentage of glycerol to the mecum encouraged the growth of the human strain but 
has no effect in bovine strain. Growth appeared as discrete colonies rose, irregular in 
shape with dry wrinkled or mamellated surface serpentine like colonies of tough and 
tenacious consistency and this confirmed the cultural characteristic of 
M.tuberculosis  the   colour of colonies at first was creamy white and later become 
buff. This is agreement with (Burman, 2000). 
However case finding by mass miniature radiography is expensive and 
impractical in most developing country and should not be used until the load of 
infection has been reduced to resizable low level when it can help in detecting  
disease in older group and in special group such as medical staff.( (Perez et al.,1999 
and Zevallos and Justmar, 2003) 
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CONCLUSION 
1. The prevalence of Mycobacterim infection (62%), however most individuals 
infected with tubercle bacilli contained the infection and did not show overt 
disease. Tuberculin testing revealed the existence of cellular immunity but can 
only suggest probability of active disease. Therefore the prevalence of 
Mycobacterim infection in contradistinction to clinical disease might be 
estimated by the use of tuberculin test.     
2. The demonstration of AFB in sputum is a good presumptive evidence of 
pulmonary tuberculosis. Such provisional diagnosis based on microscopic 
finding is of great value becomes the final identification of M.tuberculosis by 
culture or animal inoculation takes several weeks. 
3. Culture of M.tuberculosis remains essential for the final diagnosis of 
tuberculosis. Recover M. tuberculosis was isolated from the sputum of 
patients with AFB in their sputum (9.7%) 
4. LJM is reliable media for isolation of Mycobacterium as the medium   was 
prepared in screw-cap container in order to preserve moisture during the 
prolonged period of up to 6-8weeks of incubation. The malachite green dye 
inhibits growth of contaminant and treatment of sputum sample before culture 
with 4% NaOH inhibit pharyngeal commensals.       
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         RECOMMENDATION 
1. Tuberculin test can be used to suspicion of tuberculosis in patient with 
symptoms consistent with tuberculosis or in those of abnormal chest 
radiographs. 
2. Tuberculin testing can be used as screening test for contact of tuberculosis 
patient or for those with a high risk of tuberculosis through concurrent disease 
or social circumstances. 
3. Tuberculin test can be used as post vaccination check on the efficiency of 
BCG vaccination. 
4. Provisional diagnosis of tuberculosis based on microscopic findings can be 
used as a presumptive evidence of pulmonary tuberculosis. 
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APPENDIX I  
QUESTIONNAIRE  
Date ……………… 
Personal data   
Sample number ……   
 Sex 
Male               Female   
Age     ………  
Occupation   …………………… 
Medical data   
BCG-Vaccination  
Yes                 No  
Previous disease and treatment   
 Yes               No   
Previous disease and no treatment  
Yes               No  
Laboratory data    
Tuberculin test  
Diameter ___________     
Microscopic result  
Positive            Negative   
 Sputum culture 
Positive            Negative 
 
